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Positron emission tomography (PET) is a non-invasive imaging technique that visualizes the 
distribution of different molecules within the body, providing functional and molecular information 
on different tissues. PET is routinely used for staging and treatment response evaluation in oncology, 
with 18F-fluorodeoxyglucose (FDG) as the most common radiotracer of choice. Despite the fact that 
traditional evaluation is usually performed by visual inspection of the images, the current potential of 
PET relies on its capability to provide quantitative information, usually provided by a semi-
quantitative parameter known as Standard Uptake Value (SUV) that is routinely measured in most 
centers (90%). This parameter provides relatively objective tumour characterization, reliable 
differential diagnosis and earlier evaluation and monitoring of treatment response. Nevertheless, SUV 
robustness has been questioned by the scientific community, since SUV can be affected by many 
different error sources, such as physiological changes between different studies from the same patient, 
patient management issues or technical issues related to acquisition, reconstruction and quantification 
protocols. Many authors have pointed to the need for further methodology standardization in order to 
minimize the impact of these effects, which lead to the publication of different PET acquisition and 
processing guidelines by both the European Association of Nuclear Medicine (EANM) and the Society 
of Nuclear Medicine and Molecular Imaging (SNMMI). These guidelines include recommendations 
for patient preparation, acquisition protocols, tomographic reconstruction, and quantification 
procedures. Regarding the physiological variations, high blood glucose level, patient motion and high 
uptake in brown fat due to patient stress have been related to lower SUV values, while increasing 
uptake period has been related to higher SUV values. Regarding acquisition and reconstruction 
protocols, image noise significantly bias SUV, and low spatial resolution or insufficient convergence 
can lead to lower SUV values, particularly for small lesions. Finally, regarding the quantification 
procedure, SUV outcome depends on the region of interest (ROI) volume and type and SUV 
normalization. Most of these studies are carried out by using anthropomorphic physical phantoms. 
These phantoms are ideal for investigating the impact of changing technical factors on the output 
images, enabling us for applications where patients cannot serve or should not serve. The limitations 
of the physical phantoms are reduced flexibility for changing shapes and volumes of the internal 
structures, high cost and cumbersome to use. An alternative is the use of digital phantoms, so that 
simulated PET studies are generated from the projection of phantoms by using analytical or Monte 
Carlo (MC) simulation techniques. The use of MC simulation methods instead of real acquisitions for 
evaluating these factors offers several advantages, such as a controlled framework were all the 
parameters are known a priori, with low cost and with no need of using ionizing radiation.  
On this PhD thesis we developed a methodology for evaluating the robustness of SUV measurements 
based on MC simulations and the generation of novel databases of simulated studies based on digital 
anthropomorphic phantoms. This methodology has been applied to different problems related to 
quantification that were not previously addressed.  
In a first study, we evaluated the extravasation of the injected dose as an uncertainty source for SUV 
quantification. Current guidelines for whole body PET state that studies with visible dose 
extravasations should be rejected for quantification protocols. Nevertheless, taking into account the 
ratio of extravasations, this solution is suboptimal, and a correction that allows the quantification of 
these patients would be useful. We evaluated 1367 patient studies, revealing that extravasation is a 
relatively frequent effect (18%), but only with a small fraction of patients (9.5%) presenting 
quantitatively remarkable extravasations ranging from 1% to a maximum of 22% of the injected dose. 
Two methods for estimating the extravasated dose were proposed and validated in different scenarios 
using MC simulations. A criterion based on the extravasated volume and maximum concentration was 
established in order to identify the patients that might be corrected. The proposed correction 
methodology compensated the impact of extravasations on SUV values with an error below 5%, 
allowing a precise quantification of these patients.  
On a second work, we studied the impact of noise and low counting in the accuracy and repeatability 
of three commonly used SUV metrics (SUVmax, SUVmean and SUV50). This study is useful for dose 
optimization, especially in follow-up studies. Our results showed that tumour activity was 
overestimated using SUVmax for low doses and clearly underestimated using SUVmean. Instead, the 
quantification of SUV50 showed great agreement with the simulated tumour activities and only slight 
underestimation was found for very small lesions. On the other hand, SUVmean showed better 
performance than SUV50 in terms of repeatability, providing variability below 5% for all tumour sizes 
and for injected doses as low as 111 MBq.  
The same model was used to study the effect of physiological muscular uptake variations on the 
quantification of FDG-PET studies. Previous works reported that undesirably increased physiologic 
muscular uptake is frequently encountered on FDG-PET scans (12.5%). This increased muscular 
uptake can create problems in visually differentiating between normal and pathologic FDG uptake and 
it has been described as a potential cause of false positives on image visual analysis. However, the 
effect of this increased values on image quantification remained to be studied. We simulated FDG-
PET acquisitions from anthropomorphic phantoms that included different muscular uptake levels and 
three spherical lung lesions with diameters of 31, 21 and 9 mm for assessing this variability. A 
distribution of muscular uptake levels was obtained from 136 patients remitted to our centre for whole-
body FDG-PET. Different SUV metrics were calculated for different noise realizations, lung lesions 
and muscular uptake values. Our analysis showed that muscular uptake variations are one of the 
dominant error sources for FDG-PET for doses in the clinical range.  
Finally, our MC models were applied to simulate 18F-fluorocholine (FCH) studies. The aim was to 
study the effect of spill-in counts from neighbouring regions on the quantification of small regions 
close to high activity extended sources. This effect can be a drawback for 18F-based radiotracers when 
quantifying SUV near high-activity regions like the bladder. In this work, MC simulations of 
anthropomorphic phantoms with FCH biodistributions, variable bladder uptake and inserted prostatic 
tumours were used in order to obtain simulated realistic FCH data. We evaluated possible variations 
of the SUV with bladder uptake and we proposed a novel correction by appropriately adapting image 
reconstruction methodology. We showed that while the SUVs measured under these conditions are not 
reliable, images corrected using the proposed methodology provide better repeatability of SUVs, with 














A tomografía por emisión de positróns (TEP) é unha técnica de imaxe non invasiva que permite 
visualizar a biodistribución de diferentes moléculas no corpo humano, proporcionando información 
funcional sobre os distintos tecidos. A TEP utilízase rutineiramente para a diagnose, a estadiaxe e 
avaliación da resposta ao tratamento en oncoloxía, sendo a 18F-fluorodeoxyglucosa (FDG) o 
radiofármaco máis utilizado hoxe en día. Aínda que a avaliación se realiza tradicionalmente a través 
da inspección visual das imaxes, o verdadeiro potencial da TEP está na posibilidade de ofrecer valores 
cuantitativos, que son normalmente obtidos mediante o cálculo do valor de absorción estándar (SUV), 
un parámetro semi-cuantitativo que se mide rutineiramente no 90% dos centros de todo o mundo. Este 
parámetro dános unha caracterización obxectiva do tumor, criterios de malignidade/benignidade e 
valores cuantizables para a monitorización e avaliación da terapia. Con todo, a robustez dos valores de 
SUV ten sido cuestionada en numerosas ocasións pola comunidade científica, xa que estes valores 
poden estar afectados por diversas fontes de incerteza debidos a cambios fisiolóxicos entre diferentes 
estudos do mesmo doente, cambios no manexo do doente ou cuestións técnicas relacionadas cos 
protocolos de adquisición, reconstrución e cuantización. Moitos autores apuntaron á necesidade de 
estandarización dos protocolos de cara a minimizar esta variabilidade, o que se reflectiu na publicación 
de distintas guías por parte da Sociedade Europea de Mediciña Nuclear (EANM) e da American 
Mediciña nuclear e Imaxe Molecular (SNMMI). Estas directrices inclúen recomendacións para a 
preparación do paciente e para os protocolos de adquisición, reconstrución e cuantización. En canto 
aos factores fisiolóxicos, está demostrado que altos niveis de glicosa, movementos involuntarios 
durante o estudo ou a activación de  graxa parda debido ao estrés ou  ao están relacionados con valores 
inferiores do SUV, mentres que os tempos de captación prolongados poderían causar un aumento 
nestes valores. En canto aos protocolos de adquisición e reconstrución, demostrouse que niveis 
elevados de ruído poden causar variacións nos valores de SUV, e que os límites de resolución espacial 
ou un número insuficiente de iteracións nos algoritmos da reconstrución poden levar a diminucións no 
SUV. Finalmente, os valores de SUV son altamente dependentes do volume da rexión de interese 
utilizadas para a medición e do tipo de normalización escollida. A maioría destes resultados foron 
obtidos mediante a adquisición de manequíns físicos en escáneres clínicos. Estes manequíns son ideais 
para investigar o impacto destes cambios nos parámetros técnicos sobre a imaxe final, permitindo facer 
probas que non sería posibles con pacientes. Con todo, estes manequíns están limitados pola súa pouca 
flexibilidade para probar diferentes formas e volumes, o seu custo e o complexo do seu manexo. Unha 
alternativa a estes manequíns é a utilización de técnicas de simulación e de manequíns virtuais, que 
permiten a obtención de imaxes simuladas analiticamente ou mediante métodos máis complexos, como 
a simulación Monte Carlo (MC). O uso destas técnicas permítenos avaliar un gran número de factores 
nun ambiente totalmente controlado onde todos os parámetros son coñecidos, cun custo moi baixo e 
sen necesidade de manipular fontes de radiación ionizante. 
Nesta tese desenrolamos unha metodoloxía para a avaliación de diferentes métodos de cuantización 
baseados en valores de SUV utilizando a simulación MC e  para a xeración de bases de datos de estudos 
simulados de TEP-FDG, utilizando manequíns antropomórficos dixitais. Esta metodoloxía foi aplicada 
a varios problemas relacionados coa cuantización que non foran avaliados previamente. 
Nun primeiro traballo estudamos os efectos da extravasación da dose inxectada como fonte de 
incerteza para a cuantización baseada en SUV. As directrices actuais para PET de corpo enteiro 
recomendan non realizar a cuantización cando se observa extravasación, unha solución pouco eficaz 
pola alta incidencia deste fenómeno, polo que se propuxo o desenvolvemento dun método de 
corrección. 1367 imaxes clínicas foron avaliadas, mostrando que a extravasación é relativamente 
común (18%). Nembargantes, só na metade dos casos (9,5%) se observou que a extravasación 
representara máis do 1% da dose inxectada (cun máximo do 22% da dose). Dous métodos para corrixir 
este efecto foron propostos e validados mediante simulación MC, e extraéronse criterios para 
determinar a aplicación da corrección baseándose no volume e na intensidade do punto de 
extravasación. Despois da corrección, o impacto no SUV foi sempre menor do 5%, permitindo a 
correcta cuantización destas imaxes. 
Nun segundo estudo decidimos avaliar o impacto do ruído debido á inxección de doses máis baixas na 
precisión e repetibilidade dos valores de SUV calculados con tres métricas distintas (SUVmax, SUVmedio 
e SUV50). Este tipo de estudo é útil para o axuste de dose, especialmente para estudos de seguimento. 
Os resultados demostraron que os valores de SUVmax sobreestiman sistematicamente os valores de 
actividade, mentres que o SUVmedio os subestima. Os valores SUV50 foron os máis precisos 
representando o valor real de actividade, xa que só se observou unha lixeira subestimación da 
actividade en lesións moi pequenas. Por outra banda, o SUVmedio mostrou a mellor repetibilidade, 
proporcionando unha variabilidade menor do 5% para todos os tamaños de tumor e para todas as doses 
superiores a 111 MBq. 
A mesma metodoloxía foi utilizada para avaliar o impacto de cambios fisiolóxicas na captación do 
tecido muscular no SUV. Estudos anteriores informaron que os niveis altos de captación muscular 
pode crear problemas na diferenciación visual de tecido normal e patolóxico, causando a aparición de 
falsos positivos. Sen embargo, a influenza deste efecto sobre a cuantización non fora avaliado 
previamente. Simuláronse adquisicións PET-FDG dunha base de datos de manequíns antropomórficos 
con diferentes niveis de absorción muscular e nódulos pulmonares con diámetros 31, 21 e 9 mm. 
Realizáronse varias repeticións para avaliar a variabilidade. Unha distribución realista dos valores 
musculares obtívose a partir de 136 doentes aos que se realizaron probas no noso Servizo de Mediciña 
Nuclear. Os valores de SUV en base a diferentes métricas calculáronse para diferentes repeticións, 
lesións pulmonares e niveis de captación muscular. Concluíuse que as variacións musculares teñen un 
grande impacto sobre os valores de SUV, sendo un factor dominante na incerteza para os valores de 
dose utilizados na práctica clínica. 
Finalmente, os nosos modelos MC aplicáronse a outro radiomarcador, a 18F-colina (FCH), dando 
lugar á primeira base de datos de manequíns dixitais coa biodistribución deste marcador. O obxectivo 
do estudo foi o de estudar a influenza das contas entre rexións adxacentes polo efecto de volume 
parcial, o que pode afectar a cuantización de pequenas lesións que están preto de grandes áreas de alta 
captación. Este efecto pode causar problemas na cuantización de SUV en rexións próximas a áreas 
tales como o da vexiga en marcadores baseados en 18F. Simuláronse manequíns con biodistribución de 
FCH con distintas absorcións na vexiga, e valorou-se o efecto desas variacións nos valores de SUV de 
tumores de próstata. Observouse que estas variacións poden invalidar os valores cuantitativos, e 
propúxose unha corrección baseada na modificación dos métodos de reconstrución. Esta corrección 
elimina calquera rastro da vexiga na imaxe, mostrando unha reproducibilidade adecuada nos valores 
de SUV, con variacións por debaixo do 5%. Tamén se demostrou que a eliminación da vexiga por esta 










La tomografía por emisión de positrones (TEP) es una técnica de imagen no invasiva que visualiza la 
distribución de diferentes moléculas en el cuerpo humano, proporcionando información funcional 
sobre los diferentes tejidos. La TEP se usa rutinariamente para el diagnóstico, el estadiaje y la 
evaluación de la respuesta al tratamiento en oncología, siendo la 18F- fluorodesoxiglucosa (FDG) el 
radiotrazador más utilizado en la actualidad. A pesar de que evaluación de las imágenes se ha realizado 
tradicionalmente mediante inspección visual, el verdadero potencial de la TEP reside en la posibilidad 
de proporcionar valores cuantitativos, los cuales se obtienen normalmente mediante el cálculo del valor 
de captación estándar (SUV, por sus siglas en inglés), un parámetro semi-cuantitativo que se mide 
rutinariamente en el 90% de los centros a nivel mundial.  Este parámetro nos proporciona una 
caracterización relativamente objetiva del tumor, criterios de malignidad/benignidad y valores 
cuantificables para el seguimiento y evaluación de la terapia. Sin embargo, la robustez de los valores 
de SUV ha sido cuestionada en numerosas ocasiones por la comunidad científica,  ya que estos valores 
pueden estar afectados por múltiples fuentes de incertidumbre, ya sean cambios fisiológicos entre 
diferentes estudios del mismo paciente, cambios en el manejo del mismo o problemas técnicos 
relacionados con los protocolos de adquisición, reconstrucción y cuantificación. Muchos autores han 
apuntado a la necesidad de estandarización de los protocolos para minimizar el impacto de estos 
factores, esfuerzos que se han visto reflejados en la publicación de diferentes guías por parte de la 
Sociedad Europea de Medicina Nuclear (EANM) y de la Sociedad Americana de Medicina Nuclear e 
Imagen Molecular (SNMMI). Estas guías incluyen recomendaciones para la preparación previa del 
paciente y la adquisición, reconstrucción y cuantificación de los estudios. Sobre las fuentes de error 
relacionadas con factores fisiológicos, se ha demostrado que altos niveles de glucosa, los movimientos 
involuntarios durante el estudio o la captación en grasa parda debida al estrés o al frío se relacionan 
con valores de SUV más bajos, mientras que la prolongación del tiempo de captación puede provocar 
un incremento de estos valores. En cuanto a los protocolos de adquisición y reconstrucción, se ha 
demostrado que los niveles altos de ruido pueden provocar variaciones de los valores de SUV, y que 
los límites de resolución espacial o un número insuficiente de iteraciones en los algoritmos de 
reconstrucción pueden llevar a disminuciones en el SUV. Finalmente, los valores de SUV son 
altamente dependientes del volumen de la región de interés utilizada para su medición y del tipo de 
normalización que se realice. La mayoría de estos resultados se han obtenido utilizando maniquíes 
físicos en escáneres clínicos. Estos maniquíes son ideales para investigar el impacto de las variaciones 
de parámetros técnicos sobre la imagen final, permitiéndonos hacer pruebas que no serían posibles con 
pacientes. Sin embargo, están limitados por su limitada flexibilidad a la hora de probar distintas formas 
y volúmenes, tienen un coste elevado y su uso es técnicamente delicado. Una alternativa a estos 
maniquíes es el uso de técnicas de simulación y de maniquíes virtuales, que nos permiten obtener 
imágenes simuladas, ya sea analíticamente, o por métodos más complejos como el de simulación de 
Monte Carlo (MC).  El uso de estas técnicas en lugar de adquisiciones reales nos permite evaluar 
numerosos factores en un entorno totalmente controlado donde todos los parámetros son conocidos a 
priori, con un coste muy bajo y sin la necesidad de manipular fuentes de radiación ionizante.  
En esta tesis doctoral hemos desarrollado una metodología para la evaluación de diferentes métodos 
de cuantificación por SUV basada en la simulación por MC y en la generación de bases de datos de 
estudios simulados mediante el uso de maniquíes antropomórficos digitales. Esta metodología se ha 
aplicado a diferentes problemas relacionados con la cuantificación que no habían sido evaluados 
previamente. 
En un primer estudio hemos evaluado los efectos de la extravasación de la dosis inyectada como una 
fuente de incertidumbre para la cuantificación por SUV. Las guías actuales para PET de cuerpo entero 
recomiendan descartar la cuantificación cuando se observe este fenómeno, lo cual es poco óptimo 
debido a alta incidencia de este fenómeno, lo que hace necesario el desarrollo de un método de 
corrección. Se evaluaron 1367 pacientes, mostrando que la extravasación es un fenómeno 
relativamente frecuente (18%), pero que solo en la mitad de los casos (9.5%) esta representa más del 
1% de la dosis inyectada (máximo de 22% de la dosis). Dos métodos para hacer una estimación de la 
dosis extravasada fueron propuestos y validados utilizando simulación MC. Se propuso un criterio 
para aplicar la corrección basado en el volumen e intensidad de la corrección, que nos permite 
asegurarnos que el impacto de la extravasación sobre el SUV será siempre menor del 5%, permitiendo 
la cuantificación de estos pacientes.  
En un segundo estudio decidimos estudiar el impacto del ruido, debido a la inyección de dosis bajas, 
en la precisión y repetitividad de los valores de SUV para tres métricas distintas (SUVmax, SUVmedio y 
SUV50). Este tipo de estudios es útil para la optimización de la dosis, especialmente para estudios de 
seguimiento. Los estudios mostraron que los valores de SUVmax sobreestiman sistemáticamente los 
valores de actividad, mientras que el SUVmedio los sobreestiman. Los valores de SUV50 fueron los más 
preciosos a la hora de representar el valor real de la actividad, ya que solo mostraron una ligera 
subestimación de la actividad para lesiones muy pequeñas. Por otro lado, el SUVmedio mostró la mejor 
repetitividad, proporcionando una variabilidad menor del 5% para todos los tamaños de tumor y para 
todas las dosis por encima de 111 MBq.  
La misma metodología se usó para evaluar el impacto de las variaciones fisiológicas en la captación 
del tejido muscular sobre la cuantificación basada en SUV. Estudios previos habían reportado que 
valores altos de captación muscular podrían crear problemas en la diferenciación visual de tejido 
normal y patológico, propiciando la aparición de falsos positivos. Sin embargo, la influencia de este 
efecto sobre la cuantificación no se había evaluado previamente. Se simularon adquisiciones de TEP-
FDG de una base de datos de maniquíes antropomórficos que incluían diferentes niveles de captación 
muscular y nódulos pulmonares de diámetros 31, 21 y 9 mm. Múltiples repeticiones se realizaron para 
evaluar la variabilidad. La distribución realista de los valores musculares se obtuvo del análisis de 136 
pacientes remitidos a nuestro Servicio. Se evaluaron diferentes métricas basadas en SUV para las 
diferentes repeticiones, lesiones pulmonares y captaciones muscular. El análisis estadístico demostró 
que las variaciones musculares tienen un gran impacto en los valores de SUV, siendo uno de los 
factores dominantes en la incertidumbre para los valores de dosis utilizados en la práctica clínica.  
Finalmente, nuestros modelos de MC se aplicaron a un nuevo trazador, la 18F-colina (FCH), creando 
la primera base de datos de maniquíes digitales con la biodistribución de este trazador. El objetivo del 
estudio era estudiar la translocación de cuentas entre regiones adyacentes debido al efecto de volumen 
parcial, que puede afectar a la cuantificación de lesiones pequeñas que están cerca de zonas extensas 
de alta captación. Este efecto puede provocar problemas en la cuantificación de SUV en regiones 
cercanas a zonas como la vejiga en los trazadores basado en 18F. Los maniquíes con biodistribución de 
FCH se simularon con captaciones de trazador en vejiga de distintas intensidades, y se evaluó el efecto 
de estas variaciones en los valores de SUV de tumores insertados en la próstata. Se observó que estás 
variaciones podían invalidar los valores medidos, y se propuso una corrección basada en la adaptación 
de la metodología de reconstrucción. Los valores medidos utilizando dicha corrección, que elimina 
toda contribución de la vejiga de la imagen, mostraron una reproducibilidad adecuada, con 
desviaciones menores al 5%. También se demostró que la eliminación de la vejiga mediante esta 
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1 INTRODUCTION TO MEDICAL IMAGING 
 
In 1895, German physicist Wilhelm Conrad Roentgen (Figure 1.1) discovered X-
rays while he was carrying out experiments with cathode ray tubes. Roentgen quickly 
understood that this new radiation could penetrate matter, and he named it as “X” due to 
its mysterious nature. Upon the following years, he took hundreds of images, and in 1901, 
he received the Nobel Prize in Physics for the discovery and study of X-rays. The image 
of his wife’s hand wearing her wedding ring (Figure 1.2) is nowadays a symbol of the 
start of medical imaging. Unfortunately, Wilhelm Roentgen was unaware of the dangers 
of the systematic exposure to ionizing radiation, and both he and his wife died from 
cancer. Physicians quickly perceived X-rays as a new way of exploring the body and a 
revolutionary method for detecting skeletal lesions, and few years after Roentgen’s 
discovery, X-ray radiographs became an essential part of the medical equipment on 
World War I. Radiographs also became popular as a method for the assessment of 




Figure 1.1: Wilhelm Conrad Röntgen (1845-1923) 
 
A few years later (1925), Binz and Rath introduced iodine as a contrast agent for X-
ray imaging (Quader et al., 2000). Due to the small density differences between different 
soft tissues, distinguishing the borders of different organs was very challenging, reducing 
the application of X-ray imaging to bone imaging. Nevertheless, the administration of 
compounds with high electron density and atomic number facilitated the visualization of 
certain tissues and achieved enhanced contrast of certain organs. Materials as iodine and 
barium (Z = 53 for iodine, Z = 56 for barium) were administered in order to obtain better 
visualization of the digestive track and for the diagnosis of lung diseases (Lusic & 
Grinstaff, 2013).  Despite being a minor discovery compared with X-rays, the use of 
contrasts in early radiographic imaging was a precursor of the administration of contrast 
agents in modern imaging modalities, and a previous step for the development of emission 
tomography by using radioactive tracers, which is the fundament of Nuclear Medicine. 






Figure 1.2: One of the first radiographies, taken by Wilhelm Roentgen in 1895. 
 
1.1 COMPUTED TOMOGRAPHY 
 
One of the main limitations of X-ray images is that they represent a three-
dimensional object as a two-dimensional image. Thus, some parts of the body cannot be 
imaged since they are hidden behind high-density tissues. In 1956, while he was working 
on astrophysics, Ronald N. Bracewell postulated the central slice theorem, the central 
milestone of modern medical imaging. The theorem states that a three-dimensional 
distribution can be reconstructed from two-dimensional projections of the object at 
different angles. Using this property, Godfrey Hounsfield developed the first X-ray 
Computed Tomography (CT) machine in 1979 (Herman, 2009). This advancement 
granted him the Novel Prize in 1979, which he shared with Allan Cormack. The usage of 
CT has dramatically increased since then (97 million scans were performed in the United 
States in 2015), and nowadays it has applications for lung cancer screening, neurology, 
virtual colonoscopy or cardiac imaging. (Brenner & Hall, 2007). Figure 1.3 shows a 
coronal slice of a whole-body tomographic image acquired on a modern CT scanner. 
 
 
Figure 1.3: CT image of the human body, granted by the Department of Radiology, University Hospital, 
Santiago de Compostela. The image corresponds to a patient with lung carcinoma. High-density tissues 
(i.e. bone) appear bright due to high attenuation of the X-ray beams, while low-density tissues (i.e. 
lung) appear dark. 
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1.2 MAGNETIC RESONANCE IMAGING 
 
Parallel to the development of CT, in 1973 Paul Lauterbur introduced Magnetic 
Resonance Imaging (MRI) and published the first images exploiting the magnetic 
resonance phenomena discovered by Felix Bloch and Edward Purcell thirty-one years 
earlier. When any material is placed in a strong magnetic field, the spins of the protons 
of its hydrogen atoms align according to the field direction. Then, a radiofrequency causes 
the hydrogen nuclei spins to rotate around the magnetic field direction. When the 
radiofrequency source is switched off, the spins return to their rest state emitting different 
radiofrequency signals depending in the type of tissue. These signals can be measured 
and reconstructed into an image (Berger, 2002). Nevertheless, first MRI scanners had 
very bad sensitivity and needed extended acquisition times, making it impractical for the 
clinical practice. On 1977, Peter Mansfield developed echo-planar imaging, which made 
possible to acquire medical images in a few minutes and the application of MRI in the 
clinical routine. In 2003, both Mansfield and Lauterbur received the Nobel Prize for their 
revolutionary contributions to medicine. The main practical advantage of MRI compared 
to CT relies on its ability to obtain high-contrast images of soft tissue.  Furthermore, MRI 
spread quickly thanks to the fact that, in contrast with X-ray based techniques, there is no 
radiation exposure associated with the image acquisition. In Figure 1.4, we show an 
example of a T1 MRI image. T1 is the simplest MRI sequence, and it is based on the 
measurement of the relaxation times of the hydrogen nuclei once the radiofrequency pulse 
is switched off. This time varies with the molecular structure, being higher in liquids than 




Figure 1.4: Axial slice from an MRI image of a hepatic carcinoma, granted by the Department of 




In 1880, Jacques and Pierre Curie reported that ultrasound waves could create 
electricity on a quartz crystal, which was named as inverse piezoelectric effect (Manbachi 
& Cobbold, 2011). In 1929, soviet scientist Sergei Sokolov exploited this effect to 
propose the theory of sound transmission, which was used a few years later, during the 
World War II, it was used for the development of sonar. Few years after the war, in 1956, 
Ian Donald introduced ultrasound in diagnostic medicine. The ultrasound waves were 
transmitted into the body, and the return wave vibrations are converted into electrical 
pulses that are transformed into an image (Figure 1.5). Since then, ultrasound has become 
a very popular imaging modality due to the lack of secondary effects from the ultrasound 
waves (Hangiandreou, 2003). 






Figure 1.5: Ultrasound image of a fetus in the womb, viewed at 12 weeks of pregnancy. Image is 
granted by Dr. Wolfgang Moroder (Centro Medicina Prenatale Aurora, Bolzano, Italy). 
 
1.4 NUCLEAR MEDICINE 
 
Despite the huge advances provided by X-ray imaging techniques, ultrasound and 
MRI, these techniques are unable to give information about the biochemistry of cells, 
which is essential in the era of personalized medicine for the planning and monitoring of 
any specific treatment. On this regards, Nuclear Medicine uses different endogenous 
molecules, named as radiotracers, to monitor targeted biological processes. The target 
molecule is labelled with a radioactive isotope and administered to the patient in order to 
obtain biochemical and physiological information in vivo. While conventional modalities 
show only anatomical structures, Nuclear Medicine techniques can image different 
biological processes using a variety of imaging techniques, such as Single Photon 
Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET), 
which can be combined with different labelled radiotracers to provide an extent range of 
different tests (Vallabhajosula, 2009).  
 
Nuclear medicine is considered to start in 1946, when this term was first used by Sam 
Seidin in the “Journal of the American Medical Association”, where he described the 
usage of 131I for the treatment of thyroid tumours. Later, the applications of 131I in thyroid 
cancer extended to imaging and quantification of thyroid function. In these early days of 
nuclear medicine, measurements were performed by placing a Geiger counter directly 
above the organ of interest (Jaszczak, 2006), until 1958, when Hal Anger developed the 
Anger camera (Anger, 1958), allowing the two-dimensional visualization of gamma ray 
emission. In 1963, Kuhl and Edwards made the first steps of three-dimensional emission 
imaging (Kuhl & Edwards, 1963), and in 1971, Gerd Muehllehner developed the first 
SPECT system, consisting on a rotating chair placed in front of a stationary Anger camera 
(Muellehner, 1971). The same year, the American Medical Association recognized 
nuclear medicine as a medical specialty. The subsequent development of technology and 
radiotracers for SPECT was very fast, and in a few years, most cancers, such as liver, 
spleen or brain tumours could be visualized using nuclear techniques. Parallel to the 
development of SPECT, the development of PET started in 1952, a long process that 
culminated in 1989 when the FDA approved 82Rb as the first positron based 
radiopharmaceutical to evaluate myocardial perfusion. Nevertheless, PET continued to 
be most of a research tool until 1999, when glucose analogue 2-deoxy-2-(18F)-fluoro-D-
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glucose (18F-FDG) received the approval for cancer diagnostic purposes (Wagner, 2007). 
The advancements of the following decade were focused on improving the resolution and 
sensitivity of PET cameras and in the development of new radiopharmaceuticals used for 
carrying the radioactive isotopes directly to specific organs and cancer cells. Nowadays, 
nuclear medicine, and most importantly 18F-FDG PET, has become an essential tool for 
personalized medicine in specialties such as oncology, cardiology and neurology.  
 
Besides imaging, Nuclear Medicine continues to provide solutions for therapy. Using 
the same philosophy, radiopharmaceuticals emitting electrons (β- emitters), the particles 
used for radiotherapy, can be attached to adequate molecules that will deliver them to 
tumours. These electrons will be emitted locally nearby, destroying cancerous cells and 
providing an efficient treatment while avoiding surrounding healthy tissue. Most common 
therapy isotope is 131I, which has been used for the treatment of well-differentiated thyroid 
cancer for over 50 years. More recently, new treatments are being developed for more 
complex carcinomas. A good example is the use of 90Y microspheres (TheraSphere; MDS 
Nordion; Ottawa, ON, Canada), which are placed within a hepatocarcinoma vasculature, 
delivering high doses of radiation and providing lethal insult to cancerous cells, 
destroying essential tumour vascular flow, and resulting in cell death and tumour necrosis 




Analogous to CT, SPECT images are obtained from obtaining different 2-
dimensional projections by rotating an Anger gamma camera around a patient injected 
with a suitable radiotracer. In SPECT, tracers are labelled with isotopes emitting gamma 
rays. The gamma cameras need to be attached to collimators, so that only those emitted 
photons travelling in a specified direction are accepted into the projection. As in CT, 
tomographic images are obtained acquiring multiple 2D projections around the patient 
every 2-5 degrees. The 3D distribution can be reconstructed from these projections by 
using different analytical or iterative reconstruction methods (Bruyant, 2002).  
 
Figure 1.6: Coronal slices of a 99mTc-DMSA SPECT image showing the radiotracer uptake on the renal 
cortex. Image reproduced from Silva-Rodríguez et al. (2015). 




SPECT radiotracers are labelled with gamma-emitting isotopes such as 99mTc, 111In 
or 123I, with energies typically in the range between 100 keV and 300 keV. The labelling 
of different molecules with those isotopes allows assessing different biological functions, 
such as myocardial perfusion (99mTc-Sestamibi, 99mTc-Tetrasfosfin), brain perfusion 
(99mTc-HMPAO, 99mTc-ECD), bone metastases (99mTc-HDP) or renal function 
(99mTc-DMSA).  Figure 1.6 shows an example of SPECT image using 99mTc-DMSA for 




The fast development of SPECT encouraged scientists to develop new tools for 
emission tomography. From the beginning, it was well known that the use of annihilation 
radiation could solve the main problems of SPECT, which were related with the low 
sensitivity derived from the use of collimators. In contrast with the gamma emitting 
isotopes used in SPECT, PET imaging relies on the nature of the positron and positron 
decay. When the radioactively labelled radiotracer is injected into the body, the 
radioisotope atoms will decay emitting positrons (Turkington, 2001). These positrons will 
quickly annihilate with matter electrons, generating two 511 keV photons travelling in 
opposite directions, which are detected in coincidence by the PET scanner. The positions 
of detection of the two photons can be used to reconstruct the line where the positron 
annihilated or line of response (LOR) (van der Veldt et al., 2013). The lines defined by 
each gamma pair can be used to perform electronic collimation, removing the need for a 
physical collimator, making PET much more sensitive than SPECT. The annihilation and 
detection process is illustrated in Figure 1.7. 
 
 
Figure 1.7: Basic principles of PET. Modified from (van der Veldt et al., 2013). 
 
 
The first prototypes for positron imaging, with two opposed small sodium iodine 
(NaI) detectors, were developed by Gordon L. Brownell at the Physics Research 
Laboratory (PRL) in the Massachusetts General Hospital in 1952. Several versions of the 
two-detector scanner were build, but a step further was needed to significantly increase 
the sensitivity. The logical evolution was using two 2-dimensional arrays, and the result 
was the PC-I scanner (Figure 1.8) (Brownell et al., 1970), which could produce 
tomographic images on planes within the object. In 1974, Brownell had a meeting with 
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nuclear physicist Michael Ter-Pogossian, where they discussed the possibility of a 
hexagonal arrangement of detectors surrounding the patient. This meeting was crucial for 
the later development of nuclear medicine, and only one year later, Michael Phelps and 
Edward Hoffman, working in Ter-Pogossian laboratory, introduced an improved PET 
scanner with hexagonal detectors (Phelps et al., 1975). Afterwards, Brownell developed 
at Massachusetts ring and cylindrical shaped detectors (PCR-I (1985) and PCR-II (1988)) 
providing even better resolution and sensitivity (Portnow et al., 2013). Figure 1.9 shows 
the evolution of the resolution and the sensitivity of the positron imaging systems in the 





Figure 1.8: PC-I, the first tomographic imaging device. Image reproduced from (Brownell, 1999). 
 
 































2 POSITRON EMISSION TOMOGRAPHY 
 
 
2.1 PET PHYSICS 
 
2.1.1 Positron and beta decay 
 
In 1928, Paul Dirac predicted the existence of a particle that he called anti-electron, 
a particle with the mass and spin of the electron but with positive charge. Dmitri 
Skobeltsyn first observed these particles in 1929 while he was using a cloud chamber to 
study gamma radiation in cosmic rays. When a particle passes through the chamber, it 
interacts with the contained gas creating a trail, which is characteristic of each type of 
particle. In 1932, Carl David Anderson observed the same phenomena, which he 
described as “particles that acted like electrons but were curved in the opposite direction 
by a magnetic field”. He published a detailed study in the Physical Review journal, where 
he used the term “positron” for the first time (Anderson, 1933). In 1936, he was awarded 
with the Nobel Prize in Physics for his experiments, which opened the era of antimatter 
in experimental physics.  
 
The positron is the most common antimatter particle due to its low mass, and it is 
naturally produced by the decay of 𝛽+emitters. These are atoms that need to convert 
protons into neutrons to reach a more stable state with a more optimal proton/neutron 
ratio (Turkington, 2001). In 𝛽+ decay, a proton decays into a neutron, and a positron and 
an electron neutrino are emitted. The emission of the positron and the neutrino occurs in 




𝐴 → 𝑌 + 𝛽+𝑍−1
𝐴 + 𝜈𝑒 + 𝑄 
where A is the mass number (number of protons and neutrons), Z is the atomic 
number (number of protons), X is a proton–rich atom that needs to convert a proton to a 
neutron, Y is the resulting daughter atom,  𝜈𝑒  is the neutrino and 𝛽
+  is the emitted 
positron . As the resulting atom is in a more stable state, the remaining energy Q appears 
as the kinetic energy of the resulting particles. The energy of an emitted beta particle from 
a particular decay can take on a range of values up to a maximum, since the energy can 
be shared in many ways among the three particles while still obeying energy and 
momentum conservation. 
 
Natural positron emitters are rare because most nucleus are neutron rich rather than 
proton rich, and electron emission is energetically favoured over positron emission 
because neutrons are more massive than protons. Nowadays, positron-emitting 
radioisotopes are artificially produced in particle accelerators by proton bombarding or 
by using column-based generator for their usage in science and medicine. Most popular 
𝛽+emitters are, among others, 11C, 13N, 15O,18F, 68Ga and 82Rb. Table 2.1 shows some of 
the relevant physical properties of these isotopes.  
 
After emission, the positron loses its initial kinetic energy by interacting with 
surrounding matter by different elastic and inelastic interactions, deflecting the positron’s 




path through matter (Bailey et al., 2005). When the positron energy is low, the positron 
will annihilate with a matter electron. The positron range is the distance travelled by 
positron from the site of emission to the point of the annihilation. This distance depends 
both on the initial kinetic energy and on the density of the surrounding material. The mass 
of the two particles is converted to energy, emitting two 511 keV photons. This reaction 
is the basis of PET, since they will be these two photons that will be detected by the PET 
camera.  
 
Table 2.1: Most relevant artificial radioisotopes and some of their properties. 
 
2.1.2 Radiation-matter interaction 
 
2.1.2.1 Atomic level 
 
The 511 keV photons emitted in the annihilation will travel through matter in 
opposite directions, interacting with it by different mechanisms, losing energy and 
deflecting their path as it previously happened to the positron. Two interaction 
mechanisms are relevant for the range of energies of interest for nuclear medicine: 
photoelectric effect and Compton scattering (Bailey et al., 2005). 
 
In the photoelectric effect, the travelling photon is completely absorbed by an atom 
and the photon energy is transferred to an electron, which is ejected from the atom. We 
call this a photoelectron. Part of the incident energy is used to unbind the electron, and 
the rest of the energy is carried out by the electron in the form of kinetic energy. If the 
ejected electron is in an inner shell, an outer shell electron will replace it, emitting the 
excess energy as an X-ray photon. The photoelectric effect dominates in human tissue at 
energies below 100 keV, and while it is relevant for SPECT, it is of little importance for 
511 keV photons in PET. 
 
Compton scattering is a more complex interaction usually between a photon and an 
outer bound electron. An illustration of the Compton Effect process is shown in Figure 
2.1. As the electron is poorly bounded, it can be considered as a free particle. In Compton 
scattering, the photon (λ) transfers part of its energy to the electron (e-). After the 
interaction, the electron is ejected from the atom and the photon is deflected from its 
original path. The energy lost by the atom is used to unbind the electron and as kinetic 
energy of the ejected electron. Since almost all of it is given to the electron as kinetic 
energy, the photon is deflected as a consequence of the conservation of momentum, 
resulting in a photon with different direction and energy (λ’). In contrast with 
Isotope Half-life 
(min) 
Maximum Positron Energy 
(KeV) 




18F 109.80 640 1.0 Cyclotron 
11C 20.30 960 1.1 Cyclotron 
13N 9.97 1190 1.4 Cyclotron 
15O 2.03 1700 1.5 Cyclotron 
68Ga 67.80 1890 1.7 Generator 
82Rb 1.26 3150 
1.7 
Generator 
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photoelectric effect, the photon will continue travelling through matter. Not all the 
deflecting angles have the same probability, being small angles the most probable. 
Compton Effect is the dominant interaction between 100 keV and 2 MeV, and it is of 
paramount importance for PET.  
 
 
Figure 2.1: Illustration of Compton scattering. A photon 𝜆 with initial energy E0 interacts with an 
electron. The photon goes out as 𝜆′, deflected an angle 𝜃. 
 
Another radiation-matter mechanism to be remarked is pair production. When a 
photon travels carrying energy higher than 1022 keV, it can spontaneously convert its 
energy in mass under certain conditions, producing a positron-electron pair. Of course, 
as this only occurs upon 1022 keV, pair production is of no interest for PET imaging. 
 
 
Figure 2.2: Contribution of the different described processes to the total cross-section. (Source: 
Nuclear Power non-profit project) 
 
2.1.2.2 Macroscopic level 
 
Photon interactions can be expressed as atomic cross sections (𝜎) with units of 
cm2/atom or barns/atom (1barn=10-24 cm2). On a macroscopic point of view, the 
attenuation of photons in a given path is dependent on the total cross-section: 
 
𝜎𝑡𝑜𝑡 = 𝜎𝑝𝑒 + 𝜎𝑐𝑠 + 𝜎𝑝𝑝 + 𝜎𝑜𝑡ℎ𝑒𝑟𝑠 





where 𝜎𝑡𝑜𝑡 is the total cross-section, 𝜎𝑝𝑒 is the contribution of photo-electric effect, 
𝜎𝑐𝑠  is the contribution of Compton scattering and 𝜎𝑝𝑝  is the contribution of pair 
production. We named 𝜎𝑜𝑡ℎ𝑒𝑟𝑠 the contribution of other phenomena. These contributions 











where 𝑁𝐴  is the Avogadro’s number and A is the atomic mass of the material. 
Contributions of the different cross-sections to the total cross-section can be observed in 
Figure 2.2, where we can observe, as mentioned before, that Compton scattering is the 
most important mechanism for energies close to 511 keV, while photoelectric effect has 
a small contribution. These mass attenuation coefficients are very useful since they can 
be converted into linear attenuation coefficients by simply multiplying by the density in 
g/cm3. These linear attenuation coefficients represent the probability for a photon to be 




where I0 represents the photon beam intensity at point 0 and Ix represents the photon 
beam intensity at point ∆𝑥, assuming they are being emitted from a collimated source. 
The attenuation process detailed by this formula is illustrated on Figure 2.3. 
 
 
Figure 2.3: Attenuation of a photon beam by an absorber material of linear attenuation coefficient 
𝜇(𝑐𝑚−1). Figure is reproduced from (Cherry et al., 2012). 
 
In PET, as two photons are emitted in opposite directions, the count rate is only 
dependent of the total thickness of the medium, and independent of the point of emission. 
This property is used for correcting count-rates for attenuation, which will be covered in 
following sections. 
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2.2 PET DATA ACQUISITION  
 
PET acquisition is accomplished by detecting the annihilation photons produced 
when the positron interacts with an electron. This process is divided in two different steps. 
First, the energy of the photon arriving to the detector is converted into visible light 
photons by a scintillator crystal. Second, these scintillation photons are converted to 
electrical signals by a photodetector (Spanoudaki & Levin, 2010). This process is 
illustrated on Figure 2.4. The photodetector is coupled to the appropriate electronics in 
order to digitalize the signal for further processing. Despite a PET scanner has hundreds 
or even thousands of these detection elements; its performance characteristics are 
intimately related with the performance of this small blocks, so the choice and design of 
its components is crucial.  
 
 
Figure 2.4: Scheme of the PET detection process. Modified from (Beyer et al., 2010). 
 




Photons will interact with the detector material by causing ionization or excitation of 
its atoms (Cherry et al., 2012).  In the case of PET, the chosen materials are usually 
inorganic scintillator crystals that emit visible light radiation in form of scintillator 
photons when a photon interacts with the detector. The photon can deposit part or all of 
its energy in the detector. The transfer of all the energy can occur by a single photoelectric 
effect or by several successive Compton interactions in one or adjacent crystals followed 
by a photoelectric event (Humm et al., 2003). The alternative is that the arriving photon 
deposits part of its energy by one or multiple Compton events, and then leaves the detector 
carrying the remaining energy. 
 
The absorbed energy excites the crystal, which decays to its original state by emitting 
a big number of low-energy photons, usually in the range of visible light. These 
scintillation photons are collected by a photodetector (Figure 2.5); usually the 
photocathode of a photomultiplier tube (PMT), and their number is proportional to the 
energy deposited by the primary annihilation photon. In the process of choosing a 
scintillator crystal, some of its properties should be taken into account. Photon attenuation 
length is defined as the average distance that a photon will travel through the detector 
before depositing all its energy, and it is an essential parameter for crystal sensitivity. 
Photoelectric and Compton cross-sections are a function of the density (ρ) and the 




effective atomic number (Zeff) of the crystal, so these properties have to be taking into 
account when choosing a crystal for a new detector. Higher density provides higher 
stopping power, making the photons more likely to interact within the crystal, while a big 
Zeff favours photoelectric effect instead of Compton scattering. In a photoelectric 
interaction, the photon will deposit all its energy in a single event, being more efficient 
than the Compton scattering. Other important physical properties are the decay time and 
the light yield. The decay time is the time that the crystal needs to go back to a stable state 
after an interaction, being able to register a new interaction. The decay time is mainly 
related with the time that the scintillation photons need to travel through the detector, 
usually reflecting multiple times on the crystal walls, before they reach the surface of the 
photodetector. A longer decay time implies poorer timing resolution of the detector. The 
light yield is the amount of scintillation photons emitted per deposited energy, typically 
expressed in photons/MeV. A bigger number of photons implies better statistics and 
therefore better energy resolution. Unfortunately, fast response is usually related with a 
low light yield, so that a compromise between these two parameters has to be reached. 
Table 2.2 presents some of the most common scintillators in PET detectors and their key 
properties. Most used scintillators nowadays are BGO and LSO. As we can observe in 
the table, LSO has higher light yield and lower decay time. This will provide better energy 
and timing resolution, being the common choice nowadays. Furthermore, we can observe 
that LaBr3 and LuAP have excellent properties, but their high cost prevents their 
integration in commercial systems. In the case of CsI(Tl), it has the higher light yield, 
delivering excellent energy resolution, but its high attenuation length makes it deliver a 
very poor sensitivity and spatial resolution.  
 
 
Figure 2.5: When an annihilation photon enters the crystal, it interacts producing multiple scintillation 
photons, which are emitted in all the directions. The photons are likely to be reflected in the crystal 

















BGO Bi4Ge3O12 7.10 75 10.4 35 9000 300 
LSO Lu2SiO5:Ce 7.40 66 11.4 32 30000 40 
Na(Tl) Na(Tl) 3.67 51 29.1 17 41000 230 
CsI(Tl) CsI(Tl) 4.51 52 22.9 21 85000 600 
GSO Gd2SiO5:Ce 6.70 59 14.1 25 12500 60 
LuAP LuAlO3:Ce 8.34 65 10.5 30 11400 18 
LaBr3 LaBr3:Ce 5.29 47 10.4 13 70000 17 
Table 2.2: Most relevant scintillators for PET and their properties. 
 





Photodetectors are used in PET for the translation of the scintillator photons into an 
electrical signal. The used photodetector will depend on the application, taking into 
account properties as the gain or the quantum efficiency (QE). We define as QE the ratio 
of charge generated per incident photon in the photo-sensible area. Other properties as 
temperature sensitivity or magnetic field sensitivity might be also taken into account for 
certain applications. High QE and gain of the photodetector will improve the performance 














Photomultiplier (PMT) 106 1 25 1 yes cm2 
Avalanche photodiode 103 5 70 3 no mm2 
Silicion PMT 106 1 50 5 no mm2 
Table 2.3: Most relevant photodetectors for PET and their properties. 
 
The photomultiplier tube (PMT) is the most common photo-detector type for 
scintillator readout in PET. Its high gain combined with a low noise factor lead to minimal 
deviation from Poisson statistics as well as reduced statistical uncertainty in the generated 
charge signal (Spanoudaki & Levin, 2010). A PMT is a vacuum tube consisting of a 
photo-cathode, several electrodes called dynodes and an anode. The photocathode is a 
photosensitive electrode that emits charge (electrons) when scintillation photons reach 
the surface. Between the cathode and the anode, a bias voltage is applied to transport and 
amplify the electric current. Under the influence of a high potential the generated 
electrons from the photocathode drift and successively encounter the dynodes. At every 
dynode stage, the incident electrons have gained sufficient energy to create secondary 
electron emissions from collisions with the dynode, thus resulting in a large electron cloud 
at the anode and high gain. The main drawbacks of PMTs are their low QE around 25% 
and their large size, which make it difficult to couple them to very small detector crystals. 
A diagram representing the basic operation of PMTs is shown in Figure 2.6. 
 
Avalanche Photo-Diodes (APDs) are based on the activation of PIN diodes (diodes 
with a wide undoped intrinsic semiconductor region between the p-type and n-type 
semiconductor regions) due to the interaction with the arriving scintillation photons. This 
interaction is much more likely than the appearance of a photoelectron on the 
photocathode of a PMT, providing a higher QE. Nevertheless, their gain is orders of 
magnitude lower and dependent of the temperature, which degrades energy resolution. 
Nowadays, installation of APDs is reserved to special situations, as in PET/MR hybrid 
systems. 
 
Recently, Silicon Photomultipliers (SiPMs) have been introduced to address the 
different limitations of both PMTs and APDs. These devices are arrays of APDs that work 
on Geiger mode. In this mode of operation, the interaction of a photon results in a 
cumulative avalanche breakdown within the diode depletion region, improving the gain 
of the photodetector. SiPMs provide high gain and quantum efficiency and small size and 




they are not sensible to magnetic fields, which delivers good spatial, energy and timing 
resolution. SiPMs are currently replacing the usage of PMTs and APDs in system 
development. The first commercial system introducing this technology, the Vereos 
PET/CT (Koninklijke Philips NV, Netherlands), was presented on 2014. 
 
 
Figure 2.6: Diagram and basic operation of a PMT. Reproduced from (Bailey et al., 2005). 
 
2.2.1.3 Detector arrangements 
 
Scintillator crystals and photodetectors can be coupled in different arrangements. 
Most simple and intuitive is the one-to-one coupling, where each crystal is coupled to its 
own photodetector. This approach has several drawbacks. On this configuration, the 
spatial resolution is determined mainly by the size of the photodetector, and PMTs, the 
most common photodetectors in PET instrumentation, are usually several centimetres 
wide. The problem can be solved by the use of Position-Sensitive PMTs (PS-PMTs), 
multichannel PMTs with arrays of small dynodes coupled to multi-anode structures, 
which essentially divide single PTMs into very small channels that can be coupled to 
individual crystals. Despite the very good spatial and timing resolution achieved by these 
configurations, the use of very small crystals with one-to-one coupling will generate an 
electric signal per crystal. Taking into account that a clinical PET system has thousands 
of crystals, the processing of all these signals would be very complex and expensive.  
 
Anger coupling is defined as the configuration where a large continuous crystal is 
coupled to an array of PMTs. The light will spread in the crystal after the interaction, and 
each of the PMTs will receive a signal proportional to its position related to the 
interaction. A weighted centroid-positioning algorithm is used for estimation of the 
interaction position within the detector from the signals received by each PMT. Since 
these detectors involve significant light sharing between PMTs, a high light yield 
scintillator is needed for having enough statistics. Nevertheless, the main problem of this 
approach is the use of very wide crystals in PET imaging (typically 15-25 mm), which 
implies very complex light spread, especially in the crystal interface. Furthermore, the 
spread of scintillation light within the crystal leads to significant detector dead time at 
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high-count rates. Due to these limitations, Anger coupling is not used on current 
commercial systems.  
 
The usually chosen hybrid solution is using block detectors (Figure 2.7). In block 
detectors, individual small crystals are coupled to the PMTs through a light guide. The 
light guide will spread the light from the individual crystal to the PMTs, reducing the 
spread of photons generated on the continuous crystal. A modified Anger logic is then 
used to calculate interaction point based on the signal of each PMT. This solution reduces 
the light spread, improving time response of the detector while reasonably maintaining 
spatial resolution. It is the most used solution on commercial PET systems. 
 
 
Figure 2.7: Example of a block detector. The ‘block detector’ uses four PMTs (PMT A-D) to decode an 




When a photon hits the detector, the PMT emits a charge pulse proportional to the 
energy deposited on the detector. This pulse is sent to the electronics module, usually a 
pulse height analyser (PHA) to generate timing, energy and position information. 
Typically, the pulse is filtered to remove high frequency noise and converted to a digital 
signal. The PHA takes photons of a selected energy window and rejects the rest. If a 
narrow window is used, the energy discrimination is precise (small number of scattered 
photons) but the detection efficiency is low (also small number of unscattered photons) 
(Bailey et al., 2005). In the case of PET systems, the PHA window is centered on 511 
keV, typically between 350 and 650 keV for BGO (Saha, 2010). Coincidence logic is 
used to discriminate if two detected photons are coming from the same annihilation. This 
discrimination process is known as “electronic collimation”.  Usually, the PHA attaches 
a digital time stamp to every photon. The coincidence module then compares the events 
from each detector with the ones recorded in opposing detectors.  A coincidence event is 
assumed to have occurred when a pair of events are recorded within a specified 
coincidence timing window, which typically of the order of magnitude of 10 nanoseconds 
(Cherry et al., 2012). 
 
 




2.2.1.5 PET detector characterization 
 
The design of the individual detector block will determine the whole performance of 
the scanner. Several properties are used in order to characterize the performance of a 
detector block. 
 
We define timing resolution as the uncertainty in the detector timing on an event-
by-event basis due to statistical fluctuations.  The timing resolution is important since 
PET events involve the detection of two photons coming from the same annihilation 
(Cherry et al., 2012). When a photon is detected, the scanner electronics generate a narrow 
time window, and if other photon reaches the scanner within this time window, it is 
considered to come from the same positron annihilation. If the timing of the detectors is 
poor, the coincidence window needs to be wider. The timing resolution is dominated by 
the scintillator properties so that the faster the decay time of the crystal, the better the 
timing resolution. For this reason, scintillators as LaBr3 or LSO provide good timing 
resolution. Furthermore, Anger arrangements involve a high spread of scintillation 
photons (it involves multiple interactions of each scintillation photon before being 
detected in the PMT), which will lead to longer decay times and thus worse timing 
resolution (Bailey et al., 2005).  
 
The energy resolution of a detector is defined as its ability to determine the energy 
of an incident photon. The energy resolution is directly related with two main factors that 
essentially improve the statistics of the measurement, the crystal light yield and the 
photodetector gain. Na(Tl) and Cs(Tl) provide high light yields and excellent energy 
resolution, but they are combined with very poor timing resolutions. LaBr3 has excellent 
energy resolution, but at very high cost. LSO provide good energy and timing resolution 
at a reasonable price. About the photodetectors, PMTs offer the better energy resolution 
due to their very high gain (Lecoq, 2016). 
 
The intrinsic sensitivity of a PET detector is its ability to detect a photon that reaches 
the crystal sensible volume. Sensitivity is determined by the stopping power of the 
scintillator for 511 keV. The sensitivity of PET scanners increases as the square of the 
detector efficiency, which is dependent of the scintillator decay time and stopping power. 
This is why LSO, LYSO and GSO detectors are preferred to NaI(Tl) or BGO detectors 
(Saha, 2010).  
 
2.2.2 PET scanners 
 
PET scanners are arrangements of block detectors, typically axially fixed full or 
partial rings with diameters around 80 cm, as shown by Figure 2.8. The selected 
arrangement will determine the geometric efficiency of the PET scanner, defined by the 
solid angle projected by the source of activity at the detector, and dependent on the 
distance between the source and the detector and on the diameter of the ring and the 
number of rings on the detector (Saha, 2010). This angle is usually narrow, and the 
scanner covers a small area of the body. To solve this, scanners are equipped with 
movable beds so the patient can be placed at different axial positions for whole-body 
scans (Cherry et al., 2012). 




Figure 2.8: PET scanner formed by four rings of block detectors. Licensed under Public Domain via 
Commons. 
 
2.2.2.1 Event detection in PET 
 
PET scanner operation relies on the detection of coincident photons which are 
assumed to come from the same positron annihilation. The line between the arrival 
detector positions of the two photons constitutes a line-of-response (LOR), and identifies 
the line where the positron annihilated. Large numbers of these LORs are processed to 
generate images of the volumetric distribution of the radiotracer within the body. An 
event is considered a coincidence if it fulfils a couple of criteria. First, they should be 
detected within a predefined time window that is determined by the detector timing 
response. Second, both photons have deposited a certain amount of energy in the detectors 
within a range of energies known as the energy window. Due to the finite energy and 
timing resolution of PET detectors, undesired coincidences are generated in the normal 
operation of PET scanners. We can describe five different types of events in PET, named 
as trues, multiples, singles, scattered events and random coincidences (Abushab, 2013). 




Figure 2.9: Examples of true (a), multiple (b), single (c), random (d) and scattered coincidences (e). 
Reproduced from (Abushab, 2013) 
 




We consider a coincidence event a true event (a) when the scanner detectors detect 
photons from an original annihilation without having any additional interactions. In this 
case, the LOR is correctly assigned to the event.  
 
Multiple coincidences (b) are produced when three or more photons are detected in 
coincidence, not knowing which of them represent a true coincidence. These events are 
usually discarded in PET acquisitions.  
 
Single events (c) are produced when only one of the photons coming from 
annihilation is detected. These events are usually discarded, and they are by far the most 
common type of event found in PET acquisitions.  
 
A scattered coincidence (d) occurs when one of the photons has passed through a 
Compton interaction that has deflected its trajectory. If the photon and the coincident 
photon are detected, and the energy resolution is not good enough to reject the scattered 
photon, an incorrect LOR will be assigned to the event. 
 
A random coincidence (e) is recorded when two photons coming from different 
annihilations are detected into the same coincidence window. Randoms are introduced on 
the final image as a constant background. The random event count rate between a pair of 
detectors “a” and “b” can be calculated as 𝑅𝑎𝑏 = 2𝜏𝑁𝑎𝑁𝑏, where 2𝜏 is the time window 
and Na and Nb are the number of single photons detected by detectors “a” and “b” within 
a time window. As the formula is proportional to the time window, improving the timing 
resolution by choosing a faster scintillator can reduce the number of random events.  
 
Both multiple and singles events can be easily removed from the acquired data. By 
contrast, scatter and random coincidences consist on the detection of two photons and 
therefore they are recorded as valid coincidences. Ideally, only trues should be recorded, 
and in order to obtain optimal image quality, scattered and random coincidences should 
be removed by applying proper corrections, which will be discussed in upcoming 
sections.  
 
2.2.2.2 The sinogram 
 
PET data is stored as LOR histograms, which represent the number of coincidences, 
detected by each LOR. These data carry the useful information required for obtaining the 
original three-dimensional distribution of the radiotracer, and they are usually stored as a 
set of two-dimensional images called sinograms (Aguiar, 2010). A sinogram is a 
representation of the signal measured at a given angle in the imaging plane at varying 
distances along the detector array. An example is shown in Figure 2.10. 
 
Given different LORs labeled as A, B, C, D, they can be completely characterized by 
the angle of orientation (∅) of the LOR (0º for the case of LOR A) and the shortest 
distance between the LOR and the center of the scanner (s). These two parameters 
(𝑠, ∅) can be represented as points in a two-dimensional space, as in Figure 2.2.B. In the 
final sinogram, the value in each pixel represents the number of coincidence detections 
between the detectors pair associated with that LOR. For a PET scanner with multiple 
rings, sinograms are stored as multiple slices (Fahey, 2002). 





Figure 2.10: Example of PET acquisition and data storage. (A) example of PET acquisition, (B) Example 
of sinogram space. Image modified from (Fahey, 2002). 
 
Instead of sinograms, PET data can also be stored as projections, which are sets of 
(𝑠, 𝑧) data stored for each (∅) angle, as shown in Figure 2.11. Projections can be obtained 
from sinograms from reorienting the sinogram matrix. They are useful for visualization 




Figure 2.11: Projection data is stored as integrals of the activity for each s at a given angle. 
Extending the acquisition to all the z positions generates 2D projections. Figure is adapted from (Bailey 
et al., 2005) 
 
2.2.2.3 Axial Sampling 
 
A PET scanner includes several rings of detector crystals, arranged as shown in 
Figure 2.12, which defines the coordinate system of a PET scanner. A LOR can be labeled 
in the space as 𝐿(𝑠, ∅, 𝜃, 𝑧), where 𝜃 is the angle with the Z axis (axial angle) and 𝑧 is the 




position on the Z axis (axial position) and (𝑠, ∅) are the sinogram variables. We say that 
a PET scanner is operating in fully 2-dimensional mode (2D) when only coincidences 
between detectors on the same ring are accepted, which means that only  𝜃 = 0  is 
accepted. On this mode, the geometrical sensitivity of the scanner is N times the 
sensitivity of a single ring, where N is simply the number of rings, and additional rings 
only serve to increase the coverage of the object, which is known as the axial FOV of the 
scanner. A scanner running in 2D mode will store data on N sinograms, one for each ring. 
In 2D acquisition mode, the rings are usually separated with physical septa, in order to 
minimize interactions between the detectors and scattered and random coincidences. In 
order to improve sensitivity, 2D acquisition modes usually include this “direct” 
sinograms and interplanes formed between rings with a ring difference of ±1. The planes 
with ring difference of ±1 are considered physically between detector rings (Bailey et 
al., 2005). This results on a total of 2𝑁 − 1 (𝑁 direct sinograms and 𝑁 − 1 interplanes).  
 
 
Figure 2.12: Diagram and coordinate system of a PET scanner of several rings. Figure reproduced from 
(Bailey et al., 2005) 
 
In state-of-the-art scanners, the acquisition is usually performed in fully 3D-mode, 
where coincidences between any different rings are accepted. 3D acquisition was 
discarded for a long time due to the lack of efficient 3D reconstruction algorithms and 
scatter correction methods. The 3D acquisition will generate 𝑁2 sinograms, one for each 
combination of detectors, drastically improving the sensitivity of the scanner.  It has to 
be pointed that in 2D and 3D modes many coincidences are redundant, since the image 
can be reconstructed using only 2D data, but they help to increase sensitivity and thus to 
reduce noise. Nevertheless, the acceptance of all coincidences will degrade the image 
quality by including more scattered and random coincidences. We can see examples of 
the different types of acquisition modes in Figure 2.13.  




Figure 2.13: Example of accepted coincidences for fully 2D (left), 2D (center) and fully 3D (right) 
acquisition modes. 
 
In 3D acquisition, sinograms between different rings are usually grouped to optimize 
the data storage and the reconstruction time. This process can be really confusing in 
modern scanners, which can have up to 64 rings. For having a convenient representation 
of the different possible acquisition modes in a PET scanner we use graphs known as 
“Michelograms”. Figure 2.14 shows an example of the different acquisition modes for a 
PET scanner with 8 rings. Each axis is numbered from 0 to 7 to represent the 8 rings. The 
point (0,0) represents the sinogram that includes coincidences within ring 0, the point 
(0,1) represents the sinogram that includes coincidences between ring 0 and ring 1, and 
so on. In the left, we can see that sinograms are stored for (0,0), (1,1), (2,2,). Which 
corresponds to the fully 2D acquisition mode with 8 sinograms. On the center of the 
image, we can observe a Michelogram where we have sinograms for ring differences of 
0 and ±1, and the line between ±1 indicate that this sinograms are being added together. 
A set of sinograms with the same ring difference is called a segment.  The addition is 
intended to reduce the number of sinograms. Span is a number that determines how much 
axial compression is used. The presented example corresponds to span 3; while no 
addition of sinograms corresponds to span 1. This corresponds to the 2D mode with 15 
(2𝑁 − 1) sinograms in total. It has to be taken into account that sinograms with ring 
difference ±1 that are added together will have approximately the double of counts that 
the ones with ring difference 0. In the right we can see the Michelogram for a fully 3D 
acquisition, where all the 64 sinograms are stored separately (span=1). 
 
2.2.2.4 List mode acquisition 
 
An alternative to sinogram storing is list mode acquisition. We define list mode as 
the storage of events in order of occurrence in the acquisition system. In list mode, each 
event is stored sequentially in a file containing the detection position of each photon, as 
well as the photon energiy and timing information. The main advantage of list mode 
compared to sinograms is that it allows the inclusion of external information such as 
gating parameters or patient motion records for further motion correction, or timing 
information in order to perform time-of-flight reconstruction. Furthermore, list mode 




allows later binning into sinograms (Abushab, 2013; Nichols et al., 2002). In exchange, 
list-mode acquisition implies the creation, storage and management of very large files, 





Figure 2.14: Different examples of Michelograms for fully 2D (left), conventional 2D (center) and fully 
3D (right) acquisitions. 
2.3 PET DATA CORRECTIONS 
 
2.3.1 Attenuation Correction 
 
As previously mentioned, photons can interact with matter by different processes, 
being Compton Effect the dominating mechanism for energy ranges of interest for PET. 
From a macroscopic point of view, the probabilities of interaction are given by attenuation 
coefficients 𝜇/𝜌  expressed in units 𝑐𝑚2 ∗ 𝑔−1 . For a well-collimated source and a 
detector, attenuation takes the form of an exponential 𝐼 = 𝐼0𝑒
−𝜇𝑥, where 𝐼 is the intensity 
of the beam, 𝐼0  is the initial intensity, x is the material thickness and 𝜇  is the linear 
attenuation coefficient 𝜇(𝑐𝑚−1) = 𝜇/𝜌( 𝑐𝑚2 ∗ 𝑔−1) ∗ 𝜌(𝑔 ∗ 𝑐𝑚−3) . Attenuation 
coefficients and densities for different tissues and materials are shown in Table2.4.  For 
a point of emission inside the body, the detected counts between two detectors are 𝐶 =
𝐶0 ∗ 𝑒
−𝜇𝐷 where the number of photon pairs emitted through the LOR is 𝐶0, D is the total 
thickness of tissue travelled by the photon pair and 𝜇 is the average linear attenuation 
coefficient (Bailey et al., 2005). The attenuation is independent of the point of emission 
and it is a characteristic of the LOR. Thus, attenuation sinograms can be directly acquired, 
for example by using an external transmission source, in order to perform the attenuation 
correction. 
 
Material Density (ρ) (g*cm3) μ (511keV) (cm-1) 
Adipose tissue 0.95 0.090 
Water 1.0 0.095 
Lung 1.05 0.025 
Muscle 1.05 0.101 
Cortical bone 1.92 0.178 
NaI(Tl) 3.67 0.340 
BGO 7.13 0.95 
 
Table 2.4: Densities and linear attenuation coefficients for different types of tissues and materials 
(Bailey et al., 2005).  
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2.3.1.1 Positron-emitting transmission sources 
 
A common approach for measuring attenuation is using transmission measurements 
of positron emitters with very long half-life such as 68Ge (𝑡1/2 = 270𝑑) (Bailey, 1998).  
A set of two or three thin rod sources are placed along the scanner gantry and rotated 
around the scanner, exposing detectors uniformly (See Figure 2.15). A transmission scan 
usually takes 10-30 minutes to acquire for whole-body imaging. An important limitation 
of this type of correction is the high noise of the acquired data, due to the low probability 
of a photon trespassing the whole body. Therefore, transmission measurements for 
attenuation are a major source of noise.   
 
2.3.1.2 CT-based attenuation correction 
 
With the emergence of multimodality PET/CT scanners in the last decade, new 
methods to use the CT transmission data for the correction of PET attenuation have been 
studied. CT data provides lower noise and better spatial resolution when compared with 
transmission data (Kinahan et al., 2003). Furthermore, the acquisition of the CT data is 
much faster, substantially increasing patient throughput. The main challenge is the 
calculation of 511 keV 𝜇(𝑐𝑚−1) values from the low energy ones obtained with the CT 
and the translation from Hounsfield units acquired in CT to 𝜇(𝑐𝑚−1) coefficients.  
 
 
Figure 2.15: A rotating positron-emitting source is used for the acquisition of attenuation sinograms. In 
each position, LOR between the nearest detector and different opposed detectors are measured. (Bailey 
et al., 2005) 
 
2.3.2  Scatter Correction 
 
Due to the finite energy resolution of the PET detectors, certain scattered events are 
still accepted as valid coincidences by the scanner. Their fraction depends of several 
factors such as the size and geometry of the object (typically the patient), the geometry 
of the scanner, the energy window and the acquisition mode (2D or 3D). Scattered counts 
are a factor degrading the contrast of the final images, and several techniques have been 
developed in order to correct for scatter in PET. Since both scattered and true coincidence 
rates vary linearly with the administered activity, the scatter-to-true ratio does not change 




with the injected activity. In 2D acquisition, the use of retractable septa removes most of 
the scatter, delivering scatter fractions around 10%, while in 3D mode the fraction can be 
as high as 30%-50% (Polycarpou et al., 2011). The scatter fraction and the absence of 
effective scatter correction methods was one of the factors preventing the implementation 
of 3D PET scanners. First scatter corrections were performed by assuming that the scatter 
fraction is uniform for all the FOV. Assuming this, the correction is made by taking the 
counts outside the object, where true coincidences are not expected. More sophisticated 
approaches are described below. 
 
2.3.2.1  Multiple Energy Windows 
 
This empirical approach exploits the fact that a great portion of scattered photons is 
in the single photon region of the spectrum below the photopeak. Thus, data recorded in 
energy windows set in this region can be used to estimate the scatter contribution to the 
photopeak. The dual energy window (DEW) method sets the window below the 
photopeak, and estimates the scattered events on the photopeak window using the amount 
of radiation on the lower window (see Figure 2.16) (Bailey et al., 2005). The DEW 
assumes that the spatial distribution of the scatter in the photopeak energy window is 
equivalent to that in a second energy window, which is not true. Scattered events, 
registered in the Compton window, are normalized and subtracted from the photopeak 
window (Castiglioni et al., 1999). The main drawback is that scatter measurements are 
noisy and should be smoothed in order to be subtracted from the photopeak data. Apart 
from the DEW, more complex methods using three (TEW) or more windows to obtain a 




Figure 2.16: Window settings in the DEW scatter correction method. The “Main” window is centered on 
the photopeak; while the “Scatter” window is used to estimate the scatter contribution on the 
photopeak. Licensed under Public Domain via Commons. 
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2.3.2.2 Monte Carlo Simulations 
 
Monte Carlo (MC) simulations allows scattered and true coincidences to be 
simulated and stored separately, so it is a powerful tool for correcting scatter. The method 
uses the reconstructed image as the input activity map and the measured CT as an 
attenuation map for a Monte Carlo simulation. It is assumed that the number of events in 
each pixel of the image represents the original isotope concentration without the scatter 
contribution. From the simulation, separated sinograms can be obtained for scattered and 
true coincidences. The calculated scatter contribution is then used to correct the original 
data set. (Levin et al., 1995). The method can be iteratively applied to reduce the error 
produced when assuming no scatter on the original distribution. Monte Carlo simulation 
is one of the most accurate correction methods for scattered counts. Nevertheless, the 
long time required to perform simulations with enough statistics to obtain a reliable 
correction makes it unviable in the clinical routine. 
 
2.3.2.3  Single Scatter Simulation (SSS) 
 
The Single Scatter Simulation technique (SSS) is an intermediate approach that 
approximates the scatter on a given LOR by estimating only the single scatter component 
(Watson et al., 1996; Ollinger & Johns, 1993). This method exploits the fact that the 
contribution of a small scattering region of the object to a LOR can be analytically 
calculated by the Klein-Nishima equation, and thus the total amount of single scatter can 
be calculated as the sum of the contributions of many of this regions, which are named 
scatter points on the bibliography (Werling et al., 2002). The main shortcut of this 
approach is that the contributions are calculated with non-corrected data, so an 
overestimation of the scatter distribution is expected. In order to solve this problem, the 
SSS is applied iteratively inside the reconstruction (Brix et al., 1997). 
 
2.3.3 Randoms Corrections 
 
A random event occurs when the photons coming from different annihilations hit the 
detector during the same time window and they are interpreted as a coincidence. Random 
coincidences are extremely important on modern PET systems, where 3D acquisition has 
significantly increased the sensitivity of the acquisition. In order to achieve absolute 
quantification, it is important to estimate and subtract random coincidences (Brasse et al., 
2005). Different correction methods can be used. 
 
2.3.3.1 Tail Fitting 
 
Random coincidences are supposed to be approximately constant through the FOV 
of the scanner. Due to this, it is possible to estimate the number of randoms inside the 
object by fitting the tails outside the body to a Gaussian with a constant background. This 
background will give us an estimate of the ratio of random counts that can be subtracted 
to the measured counts for each LOR. This method requires that the object does not cover 
all the field of view, so the tails and background can be adequately fitted.  
 
 




2.3.3.2 Estimation from singles 
 
As mentioned in previous sections, the number of random coincidences can be 
estimated as 𝑅𝑎𝑏 = 2𝜏𝑁𝑎𝑁𝑏, where 2𝜏 is the time window and Na and Nb are the number 
of single photons detected by detectors “a” and “b” within a time window. As 𝑁𝑎 and 
𝑁𝑏  can be measured, 𝑅𝑎𝑏  can be calculated for each LOR and subtracted from the 
measured data (Cooke et al., 1984). This method has the advantage that the measure is 
performed measuring singles, which usually have very high statistics. Nevertheless, 
measuring and storing single rates is very inefficient and the method does not take into 
account the electronics dead-time arising from the coincidence processing circuitry, 
which may be an important factor in high sensitivity systems. 
 
2.3.3.3 Delayed Coincidence Channel 
 
In the “delayed coincidence channel (DCC)” method, the timestamp of one of the 
recorded coincidence photons is intentionally delayed, so only random coincidences are 
produced. This random coincidence sinogram is a good estimate of the random ratio, and 
can be subtracted from the original sinograms (Brasse et al., 2005). The advantage of this 
method is that the delayed channel has identical dead-time properties to the prompt 
channel. The disadvantage is that the statistical quality of the randoms estimate is poorer 
than in the previous method. Current DCC methods perform separate acquisitions for the 
prompt and the delayed coincidence windows.  Using this approach, randoms estimated 
sinograms could be post-processed in order to reduce the noise before subtracting them 
from the sinograms. The only significant drawback of this method (compared to direct 
subtraction of the delayed channel data) is that acquiring a separate randoms sinogram 
doubles the size of the dataset. This can be a particular problem for fast dynamic scanning 
in 3D mode, where sorter memory and data transfer time can be a limiting factor. 
 
2.3.4  Data Normalization 
 
Conventional PET reconstruction algorithms usually assume that all the LOR have 
the same sensitivity. Nevertheless, this is not true since LOR sensitivities can be affected 
by a number of different factors such as non-uniform PMT gain, variations due to the 
geometry of the scanner and physical variations of the detectors, resulting in non-
uniformity of the acquired data even when using uniform sources (Defrise et al., 1991). 
Due to this, information on the variations on sensitivity for each LOR is required for 
achieving quantitatively reliable images. The first of them is the angle of the LOR. Only 
in LORs passing through the center of the FOV are perpendicular to the detector face. 
For the rest, the LOR and the detector surface form a different angle, and the effective 
area of the detector is reduced, which also reduces sensitivity (Bailey et al., 2005). This 
phenomenon can be observed in Figure 2.17. Additionally, in a block detector system 
each detector element will have different efficiencies due physical variations on crystal 
or PMT gains. The process of correcting for these effects is called normalization, and the 
individual correction factors for each LOR are referred to as normalization coefficients 
(NCs).  





Figure 2.17: Reduction of the effective detector surface when moving away from the center of the field 
of view along the same ring. Figure reproduced from (Bailey et al., 2005). 
 
Direct normalization is the simpler method for normalization correction.  All detector 
pairs are exposed to a 511keV photon source, typically 68Ge, without any source in the 
field of view, which is known as a blank scan. NCs are calculated for each pair of 
detectors by dividing the counts for the LOR joining the two detectors by the average 
counts of all LORs (Zanzonico, 2008). Afterwards, the emission sinograms are divided 
by the calculated normalization sinograms for normalizing the PET data.  
 
2.3.5 Dead time correction 
 
A PET scanner cannot register an infinite coincidence events rate. When a 
coincidence is produced, the scanner needs a certain time to be in good conditions to 
acquire the subsequent event. Usually, the most important factor affecting the minimum 
time between two separable events is the integration time, which is the time used to 
integrate the charge arriving on the PMT from the scintillator crystal. If a new photon hits 
the detector while the charge is being integrated, both events will be considered as a single 
one, resulting in a pulse pile-up effect (Vicente et al., 2013). In this case, either both 
events are considered one with different energy and position, or more likely, they will be 
discarded due to the upper energy threshold.  
 
Coincidence processing also takes time, during which no further coincidences are 
accepted. There is also a chance that two true events occur during the same coincidence 
window. This is known as a multiple coincidence and both events are rejected. This can 
be especially problematic in modern scanners, where signals are multiplexed to reduce 
the amount of used coincidence circuitry. This shared circuitry processes many data, and 
it is an important contribution to the whole system dead time (Bailey et al., 2005).  
 
For measuring the dead time of a PET scanner, a simple experiment is usually 
performed. A uniform cylindrical source with very high activity concentration is placed 
on the center of the FOV of the scanner. Consecutive acquisitions for singles, prompts 
and randoms are performed while the activity in the field of view decays. After several 
half-lives, the activity should be very small and the effects of dead time should be 
negligible. The incident count- rate for a given level of activity in the FOV is obtained by 




linear extrapolation and is compared with the measured activity for that level, estimating 




Figure 2.18: The trues count rate is not proportional to the activity in the FOV due to dead time of the 
scanner. The net activity can be calculated from a linear extrapolation (straight line) for activities 
bellow saturation. Figure adapted from (Bailey et al., 2005). 
 
An accurate correction of dead time is not easy. The simplest approach would be to 
use the data from uniform sources for calculating correcting factors for each activity, 
using a curve as the one shown in Figure 2.18. Nevertheless, this method does not take 
into account the possible variations due to the changing shape of the source. A more 
accurate methodology is modelling each part of the system, experimentally or 
analytically, and correcting for all the sources.  Dead time models use two components 
of the dead time, “paralyzable” and “non-paralyzable”. 
 
Paralyzable dead time refers to the situation where the system is unable to process 
events for a fixed amount of time τ after each event, but the system is not dead. For 
example, after a photon hit, the detector needs a certain integration time to register that 
event but new photons can still be hitting the detector during this time. For a “paralyzable” 
case, the relation between the real (𝑁0)  and measured event rate (𝑁) follows the equation 
𝑁 = 𝑁0𝑒
−𝑛𝜏, where 𝜏 is the deat time for processing a single event. 
 
In a “non-paralyzable” scenario, the events arriving during this time are simply 
ignored. This is the case for the coincidence circuit. Events arriving while a coincidence 
is being processed are simply ignored. For a “non-paralyzable” case, the relationship 







The two components can be present in the system in series and this has been shown 
to be the case for PET systems. Each of the PET sub-systems can have one of these or a 
mixed behaviour, which can be modelled and corrected jointly or separately. 
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2.4 PET PERFORMANCE MEASUREMENTS 
 
Different parameters such as spatial resolution, statistical noise, scatter fraction, 
contrast or sensitivity are routinely assessed for both characterization and calibration of 
PET scanners. These parameters are usually dependent on each other, and getting to 
compromise solutions between them is one of the crucial tasks of scanner and protocol 
design (Saha, 2010). The evaluation of these parameters is usually performed by using 
the NEMA-NU 2007 guidelines (National Electrical Manufacturers Association, 2007) 




The sensitivity of a PET scanner is defined as the number of counts per second 
detected by the device per unit of activity in the source, and it is usually expressed in 
𝑐𝑜𝑢𝑛𝑡𝑠/𝑠 ⋅ 𝑀𝐵𝑞. The sensitivity depends on the geometry of the scanner, the efficiency 
of the crystal, the width of the energy window, and the dead time of the system (Saha, 
2010). About the geometry, current PET scanners cover a small solid angle of the patient, 
which implies low sensitivity. Due to this, patient studies are long acquisitions including 
multiple bed positions. The axial FOV may be increased by incorporating additional rings 
of block detectors in order to increase the solid angle coverage and hence the overall 
sensitivity (Eriksson et al., 2006). The intrinsic detection efficiency is the probability that 
two coincident photons traversing the scintillator crystal deposit all their energy in the 
detector. This sensitivity is related to the scintillation material decay time, density, atomic 
number and thickness (Levin, 2008). Furthermore, the energy window and the system 
dead time also have an effect on the scanner sensitivity. A wider energy window will 
provide a better sensitivity while increasing the number of scatter events. Faster 
electronics will provide reduced dead time and thus higher sensitivity in high activities. 
Sensitivity of a single ring PET can be calculated as (Budinger, 1998): 
 
𝑆 = 100




where A is the area of the detector, 𝜀 is the intrinsic detection efficiency, 𝜇 is the 
linear attenuation coefficient at 511 keV, D is the thickness of the detector and R is the 
radius of the scanner. We can observe that the sensitivity increases with the square of the 
detector intrinsic efficiency 𝜀 , which depends on the scintillator crystal choice. The 
sensitivity of current PET scanners is around 0.2-0.5% for 2D acquisitions and 2-10% for 
3D PET (Cherry et al., 2012).  
 
To evaluate the sensitivity by the NEMA-NU 2-2007 protocols, a 700 mm long 
polyethylene tube with diameter of 3 mm filled with 4 MBq of 18F and is subsequently 
covered by different widths of aluminium (2.5 mm, 5 mm, 7.5 mm, 10 mm, 12.5 mm) 
simulating an attenuation medium and acquired for 300s (see Figure 2.20). The 
measurements are repeated at positions (0, 0, 0) and (100 mm, 0, 0). The sensitivity is 
obtained by fitting to an exponential function the series of sensitivity values for different 
aluminium thicknesses (see Figure 2.20). 
 





Figure 2.20: NEMA NU 2-2007 sensitivity phantom (a) diagram (b) phantom. Figure reproduced from 
(International Atomic Energy Agency, 2009), showing the different layers of aluminium surrounding the 
source. 
 
2.4.2 Spatial Resolution 
 
Spatial resolution is defined as the system ability to separate two points after image 
reconstruction and it determines the minimum size of a lesion or structure that can be 
detected. The main factors limiting spatial resolution in PET imaging are the crystal size 
(when segmented detectors are used), the positron range, the non-collinearity of the 
emitted photons and the tomographic reconstruction algorithm. The intrinsic resolution 
of the system is defined as d/2, where d is the width of the detector crystal element. As 
an example, for scanners with typical detector sizes around 5mm, the contribution of the 
crystal size to the final resolution is around 2.5mm. Furthermore, the position where the 
positron annihilates creating the two 511 keV photons is separated from the position of 
the parent nucleus by a distance known as positron range, generating some blurring on 
the final image. Positron range is relatively low for 18F (0.54 mm), but it can be an 
important contribution for other radioisotopes such as 11C (0.92 mm), 13N (1.49 mm), 15O 
(2.48 mm) or 68Ga (2.83 mm) (Moses, 2011).  Finally, as the positron has a certain kinetic 
energy when it annihilates, the two emitted photons are generally emitted with a small 
angle of around 0.2º between them. This angular uncertainty, known as the non-
collinearity of the photons, causes a blurring on the final image proportional to the radius 
of the scanner (R), given by 0.0044R. This value is around 2 mm for current scanners of 
80-90 cm of diameter. The total resolution is calculated as: 
 
𝑅 = √(𝑅𝑖
2 + 𝑅𝑝2 + 𝑅𝑛𝑐
2 ) 
 
where Ri is the intrinsic resolution of the detector, Rp is the contribution of the 
positron range and Rnc is the contribution of the non-collinearity. This theoretical value 
would result around 3.5 mm for actual scanners. It should be convolved with the 
degradation from the reconstruction process and additional small effects such as 
electronics decoding errors, detector penetration or limited sampling (Moses, 2011). 
 
In order to evaluate the spatial resolution, the NEMA-NU 2-2007 suggest that a point 
source of 1x1x1 mm3 of 18F is placed on 4 different positions (0, 1 cm, 0), (0, 10 cm, 0), 
(0, 1 cm, (¼ FOV) cm), (0, 10 cm, (¼ FOV) cm) where the position (0,0,0) is the center 
of the field of view (FOV) of the scanner (see Figure 2.19). The activity of the point 
source should be low enough to keep the ratio of randoms to total events below 5%. The 
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obtained data should be rebinned using FORE and reconstructed using the 2D filtered 
backprojection (FBP) in a matrix of 1.0x1.0x1.0 mm3 pixels. The obtained point-spread 
function (PSF) is fitted to a Gaussian distribution in order to obtain the spatial resolution 
in terms of Full Width Half Maximum (FWHM) and Full Width Tenth Maximum 
(FWTM) (Jakoby et al., 2011). 
 
 
Figure 2.19: NEMA NU 2-2007 resolution measurement. Figure modified from (Martí-Climent et al., 
2013). 
 
2.4.3 Noise and scatter fraction 
 
One of the main factors degrading PET images is the statistical noise, which is much 
more important in PET when compared to other modalities such as CT or MRI, and a 
good characterization of the noise levels is paramount for the characterization of a PET 
system. Unfortunately, a detailed description of the statistical noise affecting clinical PET 
images is not trivial, mainly because the noise distribution is altered by data corrections 
and image reconstruction, which may destroy the Poisson properties of PET imaging 
(Teymurazyan et al., 2013). Noise ratio is given by (
1
√𝑁
) ∗ 100, where N is the number 
of counts per pixel. Thus, noise can be reduced by increasing image acquisition statistics 
(N), which can be achieved by imaging for a longer time, increasing the dose injected to 
the patient or improving the scanner sensitivity (Saha, 2010). Furthermore, post-
processing methods, mainly based on image smoothing, has also been used for improving 
noise properties while degrading other such as image resolution. In the NEMA protocols, 
the image noise in PET is characterized by a parameter named noise equivalent count 




𝑇 + 𝑆 + 𝑅
 
 
where T is the number of true coincidences, S is the number of scattered coincidences 
and R is the ratio of random coincidences.  On the NEMA NU 2-2007 protocols, noise 
and scatter fraction are evaluated by measuring the NECR. This parameter is proportional 
to the signal-to-noise ratio (SNR) on the final image. The NECR estimates useful count 
rates of a scanner by taking into account the contribution of true events and of scattered 
events and randoms to the total coincidence rate (International Atomic Energy Agency, 
2009). NECR is usually measured by making a long time measurement using a solid 
cylindrical polyethylene phantom with a line source radially offset from the centre (see 




Figure 2.21). The radial displacement of the line source is expected to give a value for 
scatter fraction that is representative of a typical PET scan (Ferrero et al., 2011). At the 
start of the acquisition, with very high activity, T, S and R will have an important 
contribution. After the activity has decayed, the contribution of random coincidences will 
go down, allowing us to calculate the scatter contribution 𝑆𝐹 = 𝑆 𝑇⁄ . This fraction 
depends on multiple parameters, mainly the activity and attenuation distribution and the 




Figure 2.21: NEMA NU 2-2007 scatter phantom. The polyethylene cylinder is used to produce scatter in 
the activity coming from the inserted line source. Figure modified from (Martí-Climent et al., 2013). 
 
2.4.4 Image quality 
 
PET image quality is influenced by a number of different performance parameters, 
such as scanner sensitivity, uniformity, image contrast and spatial resolution, and by the 
performance of the reconstruction methods. Image quality is assessed in PET by 
calculating image contrast and background variability ratios for both hot and cold spheres. 
Contrast evaluates the variations in counts between adjacent areas in the image, and thus 
detectability of the lesions in the image. Image contrast also depends on the lesion size, 
especially when the size is similar to the scanner resolution, so different sizes of spheres 
can provide different contrast values. To take into account these different parameters, the 
NEMA IEC Body Phantom contains six coplanar methacrylate spheres with diameters of 
10, 13, 17, 22, 28 and 37 mm and a polyethylene cylindrical insert of 50 mm of diameter 
(Jakoby et al., 2011).  Figure 2.22 shows the IEC Body Phantom. 
 
 
























3 IMAGE RECONSTRUCTION 
 
PET reconstruction is defined as the recovery of the original radiotracer distribution 
from the sinograms or projections obtained in a PET acquisition. Due to the limited nature 
of PET in terms of statistics and resolution, numerous researchers have focused on 
improving PET reconstruction methods (Aguiar, 2010).  This section is aimed at defining 
the reconstruction problem and presenting the most common reconstruction methods. 
 
3.1 ANALYTICAL RECONSTRUCTION METHODS 
 
The problem of image reconstruction can be formulated as a linear inverse problem: 
 
𝑠 = 𝐻𝑓 
 
where 𝑓 is the radiotracer distribution, 𝑠 are the measured data and 𝐻 is known as 
the system response matrix (SRM). The reconstruction process consists essentially on 
inverting the SRM to obtain the radiotracer distribution 𝑓  from the measured data 𝑠 
(Tong et al., 2010).   
 
This formulation assumes that data are deterministic, which is not true, but is a 
simplification used by analytical image reconstruction methods. These methods attempt 
to find a mathematical solution based on the central section theorem. This theorem states 
that the projection data is the Fourier transform of the activity distribution: 
 
𝑃(𝑣𝑠, 𝜙) = 𝐹(𝑣𝑥 , 𝑣𝑦)|𝑣𝑥=𝑣𝑟𝑐𝑜𝑠𝜙,𝑣𝑦=𝑣𝑟𝑠𝑖𝑛𝜙 
 
where 𝑃(𝑣𝑠, 𝜙) is the 1D Fourier transform of the projection 𝑝(𝑠, 𝜙): 
 





and 𝐹(𝑣𝑥 , 𝑣𝑦) is the 2D Fourier transform of the object distribution 𝑓(𝑥, 𝑦). Thus, 
the measurements in the projection space 𝜙 ∈ (0, 𝜋) allows the recovery of 𝐹(𝑣𝑥 , 𝑣𝑦) for 
the whole frequency space (𝑣𝑥 , 𝑣𝑦)  ∈ ℝ
2. Afterwards, the activity distribution 𝑓(𝑥, 𝑦) 
can be reconstructed by using the inverse Fourier transform, which is known as direct 
Fourier reconstruction (Bailey et al., 2005). 
 
3.1.1 Filtered back-projection (FBP) 
 
FBP is the most common analytical reconstruction algorithm for 2D-PET image 
reconstruction due to its low computational requirements and to its simplicity. The counts 
from each LOR are reprojected back into the image space placing a constant value into 
all the pixels along the LOR. Repeating this to all the LORs, a linear superposition of 
backprojections is obtained (Figure 3.1). 
 






Figure 3.1: Illustration of the backprojection process. At left (A) we can observe the projections 
obtained for different angles for a very simple object. At right (B), a simple example of backprojection 
for 1, 2, 8 and 256 angles. Figure reproduced from (Cherry et al., 2012). 
 
However, backprojected images are usually blurred due to the fact that counts are 
equally distributed along the LORs (Tong et al., 2010). This can be partially solved by 
filtering the data in the Fourier space, leading to a two-step inversion formula: 
 





where 𝑝𝐹are the filtered projections: 
 





and ℎ(𝑠) is the ramp filter, which is the Fourier transform of the ramp function |𝑣|. 
The objective of introducing the ramp filter is the recovery of high frequencies, which 
have been lost in the backprojection process: 
 





Of course, this formulation is an approximation based on continuous data, and some 
modifications are needed to apply FBP to discrete measured data 𝑝(𝑠, 𝜙) . Several 
problems can occur due to the limited statistics of PET, since this is an ill-posed problem. 
This means that a minimum perturbation of 𝑝(𝑠, 𝜙)  can produce a big error on the 
reconstructed image 𝑓(𝑥, 𝑦) . This happens because the ramp filer amplifies high 
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frequencies present in the statistical noise distribution, which can be solved by the use of 
a low-pass window in the frequency domain. The most commonly used is the Hamming 
window ( Baghaei et al., 2003). Image comparison between direct and filtered 




Figure 3.2: Comparison between direct and filtered backprojection for different numbers of 
projections/angles.   
 
3.1.2 3DRP and Rebinning Algorithms 
 
FBP is straightforward for 2D data, but its implementation for 3D data requires some 
modifications due to the limited axial extent of scanner ( Baghaei et al., 2003), which 
truncates some of the projections depending on the object’s position (see Figure 3.3). To 
solve the problem, 3D FBP algorithms reconstruct the image using the 2D algorithm first, 
and then use the reconstructed image to perform an analytical projection on 3D, filling 
the missing truncated projections. After that, the data can be reconstructed in 3D using 
combined measured and projected data. Another approach to reconstruct 3D data is to 
convert the 3D data into 2D sinograms that contain one sinogram for each axial position, 
and then use the 2D FBP algorithm for the reconstruction. These factoring methods are 
known as rebinning algorithms, being the simplest the single slice rebinning (SSRB), 
which assigns the sinograms between two different rings to a new sinogram lying between 
them in the axial direction (Daube-Witherspoon & Muehllehner, 1987). This approach is 
good for reduced and centered objects, but it produces large errors with radially extent 
objects. In multi-slice rebinning (MSRB), the oblique LORs are rebinned into different 
direct sinograms, improving the resolution while increasing noise (Lewitt et al., 1994). 
Further than this, the most extended algorithm is the Fourier rebinning (FORE), where 
the oblique LORs are rebinned using the frequency-distance information on the Fourier 
space (Alessio et al., 2006), and which is more accurate than the SSRB and MSRB.  In 
FORE, the oblique rays are rebinned into 2D sinograms based on the frequency-distance 
relationship in the Fourier space (Defrise et al., 1997). The continuous Fourier transform 
of the sinogram 𝑝𝑠(𝑠, 𝜙, 𝑧, 𝑡𝑎𝑛𝜃) is calculated as: 
 
𝑃𝑠(𝑤, 𝑘, 𝑧, 𝑡𝑎𝑛𝜃) = ∫ 𝑑𝜙 𝑒












where 𝑤  is the continuous spatial frequency of the Fourier transform, 𝑘  the 
azimuthal Fourier index, and  𝑧 =
𝑧𝐴−𝑍𝐵
2
   is the axial position of the new sinogram. The 
Fourier rebinning is based on the following approach: 
 





which makes very easy to calculate 𝑃𝑠(𝑤, 𝑘, 𝑧, 0) from the measured oblique 
sinograms. Then, each generated sinogram 𝑃𝑠 can be normalized for the contributions, 
which it has received, and the inverse Fourier transform can be used to obtain the rebinned 




Figure 3.3: Axial view of a PET scanner. Extend of the different projections for different Θ angles. 
Figure adapted from (Badawi, 1998). 
 
3.2 ITERATIVE RECONSTRUCTION 
 
The analytic reconstruction algorithms are simple and predictable, but they assume 
that the measurements are noise-free, and statistical noise is a very important issue in PET 
imaging. Due to this, reconstructed images can be noisy, low-contrasted of and usually 
include artifacts, which degrades the image quality. These limitations boosted the 
development of iterative reconstruction algorithms based on statistical approaches. 
Iterative reconstruction starts with an estimate 𝑓0(𝑥, 𝑦), which can be a simple shape as 
a cylinder. The estimate is forward-projected using the SRM of the scanner, and the 
calculated projections 𝑝0(𝑟, 𝜙), are compared with the measured projections 𝑝(𝑟, 𝜙). The 
differences between 𝑝0(𝑟, 𝜙) and 𝑝(𝑟, 𝜙) are used to modify the estimate 𝑓0(𝑥, 𝑦) and 
generate a new estimate 𝑓1(𝑥, 𝑦). This process is repeated until the difference between 
both sets of projections falls below a pre-set level (Cherry et al., 2012).  Figure 3.4 shows 
a schematic view of the iterative reconstruction process. 





Figure 3.4: Schematic view of the iterative reconstruction process. Image adapted from (Cherry et al., 
2012). 
 
The main disadvantage of iterative reconstruction is the time needed for the 
reconstruction. Furthermore, the non-linearity makes it less predictable than conventional 
methods. Nevertheless, iterative reconstruction methods do not produce the artifacts 
observed in analytical methods, providing better signal-to-noise ratios. Overall, iterative 
methods reduce noise providing high-quality images and are currently included in all PET 
systems (Saha, 2010).  
 
3.2.1 Maximum Likelihood Expectation-Maximization 
 
Maximum Likelihood Expectation-Maximization (ML-EM) was one of the first 
iterative reconstruction methods applied to PET. It is based in the EM algorithm, which 
is widely used in different computer science applications such as machine learning, 
natural language processing or psychometrics (Aguiar, 2010). This algorithm deals with 
the discrete nature and the high noise of PET data. It requires the calculation of a SRM 
where each element 𝑖𝑗 represent the probability of a positron emission in voxel j to be 
detected in the LOR i, being the measured projection 𝑝𝑗: 
 
𝑝𝑗 = ∑ 𝑎𝑖𝑗𝑓𝑖 
 
where 𝑓𝑖  is the radiotracer distribution and 𝑎𝑖𝑗  are the elements of the SRM. The 
reconstruction inverse problem consists, in this context, in obtaining the radiotracer 
distribution 𝑓𝑖  from the measured projections 𝑝𝑗 . This could be done by inverting the 




SRM, but this is not possible since it requires too many computational resources. The 
ML-EM algorithm is used to find a solution such that the estimated image produces the 


















𝑘 is the estimate at iteration k and ∑ 𝑎𝑖𝑚𝑓𝑚
𝑘
𝑚  are the projections obtained by 
forward-projecting 𝑓𝑗
𝑘 . ML-EM produces a solution such that ∑ 𝑎𝑖𝑚𝑓𝑚
𝑘
𝑚 = 𝑝𝑗  with a 
given likelihood. This likelihood will increase with the iterations to a maximum value, 
while the noise also increases after each iteration (Aguiar, 2010). A compromise must be 
established between likelihood and noise level to decide the number of iterations to be 
made. In contrast with analytic reconstruction methods, in MLEM corrections for scatter, 
randoms and attenuation or normalization factors can be incorporated into the SRM 𝑎𝑖𝑗 
(Hutton, 2011). 
 
3.2.2 Ordered Subsets Expectation-Maximization (OSEM) 
 
The main problem of ML-EM is that it is too slow, especially in 3D PET, where 
computing the SRM requires a very large amount of memory and computation time. 
Ordered Subsets Expectation-Maximization (OSEM) (Hudson & Larkin, 1994) is a 
modification of the ML-EM equation that makes the application of the method to clinical 
data more practical, and nowadays both 2D and 3D OSEM are commonly included on 
commercial systems. The projection data are divided in S disjoint angular subsets S1, 
S2,…..,Ss.., and the ML-EM algorithm is applied separately for each subset, which is 
known as a sub-iteration. The LOR data is separated in order of the projections into subset 
should be carefully chosen in order to maximize the new information at each sub-
iteration. Then, the ML-EM equation updates the estimate for each subset, updating the 
estimate 𝑞𝑖
















The convergence is accelerated by a factor similar to the number of subsets S, which 
makes possible to use iterative reconstruction in clinical scanners. Figure 3.5 shows a 
comparison of different 3D reconstruction methods, showing the improvements on noise 
handling and the absence of artifacts of OSEM when compared with analytical 
reconstruction. 
 
3.2.3 New developments on iterative reconstruction 
 
3.2.3.1 Including physical effects into the SRM 
 
Both ML-EM and OSEM assume that the measured data follow a Poisson noise 
distribution; so that the variations of counts for each LOR due to PET low counts are 
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independent from one LOR to another. This is true for raw uncorrected data, but the 
correction of effects such as attenuation, scatter, random coincidences or normalization 
over projection data could invalidate this precondition. Due to this, these physical effects 
should be included in the SRM or modelled into the reconstruction. Since the coefficient 
𝑎𝑖𝑗 in the SRM is influenced by the attenuation or the probability of attenuation from the 
point of emission to the detector (Hutton, 2011), this effect can be included into the SRM.  
More commonly, an estimate of the scatter, calculated by one of the previously described 
















where S is the scatter distribution. The SRM can be also easily modified to include 
information about the system resolution through the point spread function (PSF) and 




Figure 3.5: Comparison of different reconstruction methods including 3D reprojection (3DRP), FORE 
rebinning followed by 2D OSEM reconstruction and 3D OSEM. 
 
3.2.3.2 Reducing noise 
 
One of the main concerns in image reconstruction is handling the inherent noise in 
functional imaging data. In iterative reconstruction, noise increases with the number of 
iterations, and stopping the algorithm at earlier iterations is not optimal due to lack of 
convergence. Post-reconstruction smoothing can be applied after the reconstruction 
process, but with the consequent reduction of resolution. As alternative, ‘prior’ terms can 
be introduced to include additional information into the reconstruction, which has 
demonstrated to reduce image noise. The maximum a-posteriori (MAP) algorithm 
(Hebert & Lealhy, 1989) uses a penalty term, usually a function of the values in the 
immediate neighborhood of each voxel, which reduces noise by penalizing differences in 
between adjacent voxels. The MAP algorithm equation is as follows: 






















where 𝑈(𝑓) is the penalty term and 𝛽 is a scaling constant. Furthermore, additional 
terms providing additional information about the object, as separate anatomical images, 
can be introduced to ensure that the activity distribution is preserved. 
 
3.2.3.3 Time of Flight (TOF) 
 
Most recent scanners are equipped with Time of Flight (TOF) capabilities. Good 
timing resolution of a PET detector can be used to estimate the annihilation point between 
the two detectors by looking at the difference of arrival time between the two 
photons (∆𝑇). This process is illustrated in Figure 3.6 (reproduced from (Kadrmas et al., 
2009)). This estimation provides improved contrast and signal-to-noise ratio due to a 
reduction in noise propagation during the image reconstruction process (Bailey et al., 
2005) and a faster convergence in the reconstruction algorithm. Clinical studies have 
demonstrated that the incorporation of TOF provides better lesion detectability, especially 




Figure 3.6: The difference between arrival times (∆𝑇) provides an estimation of the emission point (𝑑). 
 
3.3 THE STIR LIBRARY 
 
STIR (Software for Tomographic Image Reconstruction) is an open-source software 
package written in C++, consisting of classes, functions and utilities for 3D PET image 
and SPECT image reconstruction (Thielemans et al., 2012). STIR provides the essential 
building blocks for image reconstruction, projection, and basic manipulations like format 
conversion, math operations and filtering. It provides libraries for two-dimensional and 
three-dimensional FBP, ML-EM and OSEM reconstruction. On its second release (STIR 
2.0), STIR incorporates new scanner geometries, flexible and modular designs and 
additional features such as single scatter simulation (SSS), MAP penalties and additional 
iterative reconstruction algorithms. In its next release, STIR will incorporate TOF 




























4  CLINICAL PET 
 
PET has always been exciting because of the potential application of new ligands in 
the clinic. Nevertheless, in contrast with SPECT, this potential has not been fully 
delivered, and PET is nowadays dominated by one single radiotracer, glucose analogue 
2-deoxy-2-(18F)-fluoro-D-glucose (18F-FDG), which is sometimes complemented by a 
reduced number of alternative tracers (Farwell et al., 2014). Anyway, 18F-FDG-PET 
yields excellent quality images, which can be appreciated by non-nuclear medicine 
clinicians in the first term, but also have an enormous clinical impact, as demonstrated in 
many early studies, most of them summarized by Gambhir et al. (2001). 18F-FDG-PET 
can be used for studying brain metabolism, myocardial viability, infections and 
inflammations, and of course for detecting cancer, with thousands of studies being 
performed worldwide every day. Results from the National Oncologic PET Registry, 
which included data from 85,658 patients with a wide variety of cancer types, concluded 
that FDG-PET imaging changed physicians’ intended management in about 36% of 
patients (Hillner et al., 2012), making PET an essential part of patient management.  
 
4.1 FDG-PET IN ONCOLOGY 
 
In the 1920s, Warburg reported that cancer cells have abnormally high rates of 
glycolysis. Even when tumour cells have sufficient oxygen supply, they prefer to produce 
energy using anaerobic glycolysis followed by a transformation of pyruvate into lactic 
acid. In addition, tumours often overexpress glucose transporters (GLUTs), allowing 
energy-independent transport of glucose across the cell membrane. In tumours, GLUT-1 
is frequently overexpressed, but other transporters such as GLUT-2, GLUT-3, GLUT-4, 
GLUT-5, and GLUT-12 have been reported to present elevated levels in several tumours 
types (Szablewski, 2013). This mechanism offers a very general approach for cancer 
detection, especially for staging new or recurrent cancers. Most commonly imaged 
cancers with FDG-PET include lymphoma, head and neck cancer, lung, colorectal cancer, 
breast cancer, oesophageal cancer, melanoma, cervical cancer, thyroid cancer, and 
pancreatic cancer (Kelloff et al., 2005). Figure 4.1 shows an example of a solitary 
pulmonary nodule imaged with FDG-PET. Others such as prostate cancer, bladder 
cancer, neuroendocrine cancer, and well-differentiated hepatocellular carcinoma, are 
often not contrasted enough in FDG-PET for different reasons, usually high uptake on 
surrounding tissue, while thyroid and breast tumours show very variable FDG uptakes 
(Hoh et al., 1998; Eubank & Mankoff, 2004), being susceptible to the use of other specific 
tracers.  
 
One of the main weaknesses of 18F-FDG comes from its main strength. Its unspecific 
nature allows using 18F-FDG in a wide variety of applications, but it also causes a high 
ratio of wrong or inconclusive diagnostics. Since elevated glycolysis is not limited to 
cancer cells, false-positive findings are still relatively common on 18F-FDG-PET (Kelloff 
et al., 2005). Typical alternative causes of increased FDG uptake may include infectious 
and inflammatory processes, muscular activity or metabolism in brown fat. Due to this, 
new radiotracers for cancer diagnostics and treatment planning have been under 
development on recent years (Farwell et al., 2014).  
 






Figure 4.1: Patient with lung cancer imaged with FDG-PET. Image is reproduced from (Kaira et al., 
2009). Dark colours indicate high uptake, while light colours indicate low uptake. The dark spot in the 




18F-FDG Glucose Analogue 
18F-NaF Chemisorption onto hydroxyapatite 
11C-choline Lipid-metabolism agent associated with overexpression of choline kinase 
18F-choline Lipid-metabolism agent associated with overexpression of choline kinase 
68Ga-PSMA Low molecular weight urea-based PSMA inhibitor 
11C-acetate Lipid-metabolism agent associated with overexpression of fatty acid synthase 
18F-FLT Expression of thymidine kinase 
18F-FMISO Accumulation in hypoxic cells via covalent binding 
11C-MET Amino acid transporters 
18F-FET Amino acid transporters 
18F-FMT Amino acid transporters 
18F-FDOPA Amino acid transporters 
 
Table 4.1: Overview of Current PET tracers for cancer imaging. Data from (Farwell et al., 2014) and 
(Sharma, 2014). 
 
Table 4.1 summarizes some of the radiotracers for oncology PET that are on the 
clinic or in clinical trial research nowadays. Many of them are related with increased 
protein synthesis in tumours because of their uncontrolled and accelerated growth. 
Increased protein synthesis expression is an excellent target for tumour imaging, and 
radiolabelled amino acids such as 11C-methionine (MET), 18F-fluoroethyl-tyrosine 
(FET), 18F-fluoromethyl-tyrosine (FMT) and 3,4-dihydroxy-6-18F-fluoro-L-
phenylalanine (FDOPA) have been of great interest for the molecular imaging community 
(Dolfi et al., 2013). MET-PET and FDOPA have been extensively tested for the initial 
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diagnosis, grading, prognostication and treatment planning of cerebral gliomas and for 
distinguishing benign from malign tissue in head and neck cancer, melanoma and ovarian 
cancer (Inoue et al., 1996). Figure 4.2 shows a comparison between FDG and FDOPA in 
a glioma patient. Another molecule that has raised interest along the community is 
choline, a compound that supports the synthesis of cell membranes. 18F-fluorocholine 
(FCH) molecule labelled with 18F showed the highest biological compatibility with 
choline, showing a biodistribution very similar to that of natural choline. This molecule, 
and its 11C and 18F labelled equivalents have been extensively used for the evaluation of 
prostate cancer (DeGrado et al., 2001), which has been strongly related with elevated 
levels of choline uptake and certain choline metabolites. More recently, prostate-specific 
membrane antigen (PSMA) labeled with 68Ga have shown promising results on the 
accurate staging of primary disease and restaging of recurrent detection of metastatic 




Figure 4.2: A glioma imaged with FDG (top left) and FDOPA PET (bottom left). We can observe the 
higher contrast of the amino acid imaging when compared with FDG. We also can see the much better 
correspondence between FDOPA and MRI image (top right). Bottom right shows FDOPA/MRI co-
registration. Image is reproduced from Intech Open Acces library (DOI: 10.5772/62823) 
 
Another interesting property of cancer is tumour hypoxia, which has been associated 
with treatment failure after radiotherapy and chemotherapy, and biomarkers for 
measuring the degree and extent of tumour hypoxia have the potential to play a significant 
role in staging and treatment planning for a wide variety of tumour types. During the last 
20 years, different radiotracers have been developed intended to measure this key 
property (Sun et al., 2011). Of them, 18F-fluoromisonidazole (FMISO) has the largest 
body of preclinical validation studies and clinical experience. Recent studies have 
demonstrated that tumour hypoxia measured by FMISO-PET is predictive of patient 
outcome and that hypoxic tumours have considerably earlier relapse or progression (Lee 
et al., 2009). Due to this, FMISO is a promising radiotracer to complement primary 




diagnostic with FDG, combining both metabolism and hypoxia information for treatment 
planning. 
Further than primary diagnosis, detection of recurrence and treatment planning, 
FDG-PET has demonstrated to be useful for treatment monitoring and post-treatment 
response assessment. Many studies have shown that FDG-PET is useful for detecting 
early response, which is highly correlated with clinical outcome. The objective is to 
evaluate the effectiveness of the therapy faster than it is feasible through symptoms or 
other clinical parameters, which could allow for earlier changes to new therapeutic 
regimes in patients who are not responding. A recent study has pointed that PET changed 
intended management in about 50% of patients, including a switch to a different therapy 
in 27% of patients, an adjustment in dose or duration in 17% of patients, and a switch 
from therapy to observation or supportive care in 6% of patients (Hillner et al., 2008). 
These findings pointing that FDG-PET is capable of demonstrating changes in tumour 
biology hours to days after starting therapy are revolutionary when compared to 
conventional response measures by CT, which take weeks to months to evolve and can 
be misleading at early time points. Beyond 18F-FDG, alternative radiotracers have been 
proposed for evaluating effective response to therapy based on different tumour 
characteristics. In this regard, a decline in proliferation is one of the earliest events in 
response to effective cancer therapy (Bading & Shields, 2008). The correlation between 
18F-FDG uptake and cellular proliferation is not very strong, but the alternative tracer 18F-
fluorothymidine (18F-FLT), a thymidine analogue, demonstrates a much closer 
correlation between uptake and labelling with Ki-67, a cellular marker of proliferation, 
and can be used in combination with 18F-FDG to assess response to therapy (See Figure 
4.3) (Weber, 2010). Several studies have shown the ability of FLT-PET to measure 
tumour response after two weeks of treatment on different types of cancer, such as 
recurrent malignant brain neoplasms or breast cancer, showing a strong correlation 





Figure 4.3: Comparison of FDG PET (left) and FLT PET (right) on a patient with esophageal cancer. 
Reproduced from (van Westreenen et al., 2005). 
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4.2 PET IN NEUROLOGY 
 
Glucose is the main energy supply for the brain. Its metabolism maintains ion 
gradients and glutamate turnover and is closely coupled to neuronal function at rest and 
during functional activation (Sokoloff, 1977). Due to this 18F-FDG-PET is extensively 
used for the investigation of brain metabolism and it is increasingly being proposed for 
many diagnostic purposes (Jones & Rabiner, 2012). The most common indications of 
brain 18F-FDG-PET are early diagnosis of different dementias, differential diagnosis 
between Alzheimer’s disease (AD) and frontotemporal dementia (FTD) (Herholz et al., 
2002), pre-surgical evaluation of refractory epilepsy (Van Paesschen et al., 2007) and 
differentiation between Parkinson disease and atypical parkinsonian syndromes (Eckert 
et al., 2008). 
 
In dementia, FDG-PET has a sensitivity of 93% and specificity of 76% in identifying 
progressive dementia in patients undergoing evaluation for cognitive impairment, and it 
exhibits characteristic hypometabolism patters for each of the diseases (Silverman et al., 
2001). Alzheimer is characterized by hypometabolism in temporoparietal areas, which 
can be easily differentiated from frontal patterns in FTD or occipital affectation of 
dementia with Lewy bodies.  Furthermore, PET evaluation before and after therapy with 
drugs as donepezil or rivastigmine is helpful in assessing the treatment benefits (Kumar 
et al., 2005). Furthermore, since AD is characterized by an abnormal accumulation of 
beta-amyloid plaques in certain areas of the brain, specifically binding compounds are 
being developed from radiolabelled beta-amyloid antibodies. The most widely validated 
of these radiotracer compounds is N-methyl-[11C]2-(4’-methylaminophenyl)-6-
hydroxybenzothiazole, known as Pittsburgh Compound-B (11C-PIB), showing a marked 




Figure 4.4: 11C-PIB images of a normal healthy subjet (left) and an Alzheimer’s disease patient (right), 
showing accumulation of the radiotracer in amyloid plaques. Figure is reproduced from (Porcello et al., 
2016) 
 




Regarding epilepsy, interictal 18F-FDG-PET is routinely used as a complement for 
MRI in the localization of the epileptogenic focus before surgery (Fuster et al., 2013) 
(Spencer, 1994). FDG-PET shows hypometabolic foci on the affected areas, and it has 
demonstrated to be more sensitive than MRI in certain situations (Won et al., 1999; 
Kassem et al., 2013). Furthermore, the usefulness and sensitivity of PET have increased 
in the later years by two main facts. First, the availability of co-registered PET/MR 
images has improved the interpretation of images of both modalities and enabled a more 
straightforward use of PET information on MRI-guided surgery (Shin et al., 2015). 
Second, the use of PET quantification techniques has improved the localization of the 
epileptogenic focus (Kim et al., 2002; Lee et al., 2002). Figure 4.5 shows an example of 
an epilepsy PET/MR image. 
 
 
Figure 4.5: PET/MR co-registered image of a patient with temporal lobe epilepsy. Image is granted by 
the Molecular Imaging Research Group at IDIS (Santiago de Compostela). 
 
4.3 PET IN CARDIOLOGY 
 
In cardiology, PET is dominated by two radiotracers nowadays. The first one is 
cardiac perfusion measuring agent 13N-ammonia, and the second one is 18F-FDG, which 
can be used for evaluating myocardial viability after heart strokes. PET/CT indications 
have grown in last years, particularly for the diagnosis of the ischemic myocardium, 
obstructive coronary artery disease, and large vessel arteritis, in direct competition to 
using stand-alone CT and MR imaging for these applications. (Steiner, 2011). 
 
4.4 FUTURE DEVELOPMENTS 
 
PET imaging future will be determined by the arising of new radiotracers. Artificial 
beta emitters can be generated from common biological elements such as carbon (11C), 
nitrogen (13N), oxygen (15O) and fluorine (18F), that can be attached to molecules with 
either no or minimal impact on their behaviour in the body. This approach will allow to 
label any molecule of interest and to track its path through the body with minimal 
interference in the near future, placing PET as one of the most interesting technologies in 
the era of personalized medicine. Furthermore, technical developments will also drive the 
widespread of PET. Scanners are becoming significantly more sensitive leading to 
considerably faster patient throughput, and multimodality imaging, mainly PET/CT, has 
allowed combining molecular and anatomical imaging (Eubank et al., 1998). 
Furthermore, it allows us to perform PET simultaneously with CT in situations where CT 
would be the modality of chose on previous times, enabling an easier incorporation of 
PET on clinical routine. Recently, PET/MR imaging systems have hit the market 
promising to revolutionize the scene, but their clinical applications are still unclear. 
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However, the greatest benefits of multimodal imaging may eventually come from 
software, rather than hardware, because of the flexibility and cost-effectiveness of co-
registering multiple imaging modalities as well as sequential PET acquisitions over time, 
which will be of increasing importance for PET-based treatment response follow-up. The 
true power derived from quantification will be revealed, as measurements of early tumour 
responses becomes routine practice. Many of these benefits come from the investment of 
time and money that industry is putting into PET as it is increasingly perceived as a major 
area of expansion in medicine. With increased patient throughput and a greater number 
of PET scanners and imaging resources, there are opportunities for PET to be used for 
current SPECT-based studies such as bone scans with 18F-F-, cardiac perfusion and 
viability studies, and many other (e.g. imaging neuro- endocrine tumours using [111In]-
octreotide or [131I]- mIBG). A lot will depend on the inventiveness of the cyclotron 






























5 PET QUANTIFICATION 
 
The main advantage of PET when compared with other imaging modalities is the 
possibility of providing absolute or relative quantification values characterizing 
physiological and molecular processes; especially for the diagnosis, staging and treatment 
evaluation of cancer (Buvat, 2007). Image quantification needs two essential steps. The 
first step consists on translating the given counts from the detectors to measurements of 
radiotracer concentration. This step includes the introduction of the different corrections 
and proper image reconstruction, as explained in the previous sections. The second step 
is to propose physiological models describing the system in order to obtain meaningful 
quantitative parameters from these numbers of counts. These quantitative values result in 
a much deeper interpretation of the data when compared with the conventional visual 
interpretation of the images (Basu et al., 2011). This is especially relevant for differential 
diagnosis, when comparing a parameter value with a certain previously established level 
can help to assess the malignancy/benignancy of a tumour or for therapeutic management 
and follow-up, where quantification values for different stages of the disease are 
compared for evaluating the evolution of the disease or the efficiency of the treatment. 
Thus, quantification enables objective tumour characterization, reliable 
benignity/malignancy differential diagnosis, and early evaluation and monitoring of 
treatment response (Freudenberg et al., 2008; Weber, 2005).  In the clinical routine, this 
quantitative evaluation is mainly based on a semi-quantitative parameter known as 




The concentration of radioactivity (i.e. FDG) in a certain tissue depends on two main 
factors. First, the physiology of the given tissue and its avidity for the given molecule. 
Second, the input function, or the availability of the particular substance in the blood flow 
to fulfil this avidity (Bailey, 1998). In theory, it is possible to develop a mathematical 
model that can predict the amount of FDG in a given tissue knowing both of these 
variables, which in PET research is known as kinetic modelling. However, this requires 
the acquisition of dynamic data and continuous arterial blood sampling to obtain the input 
function, which is impractical for clinical practice (Hess et al., 2014). The risks of 
excessive bleeding, bruising and infection are too big to be clinically assumed. Due to 
this, a simpler semi-quantitative parameter known as Standardized Uptake Value (SUV) 
is usually used in the clinic, using a static image instead of dynamic acquisitions. The 
SUV reflects FDG uptake in a ROI at a certain time after FDG injection, assuming that 
the activity curves have reached a plateau in the given region. SUV is usually normalized 
to the injected dose and to the patient’s body weight. SUV can be calculated by the 







where 𝑐𝑎𝑐𝑡  is the measured activity, 𝐷  is the injected dose and 𝐵𝑊   is the body 
weight, which is used as an approximation of the body volume. Usually, maximum SUV 
(SUVmax, where 𝑐𝑎𝑐𝑡  is the higher activity concentration on the ROI) or mean SUV 
(SUVmean, where 𝑐𝑎𝑐𝑡  is the average activity concentration on the ROI) are reported. 




Different studies have shown the correlation between SUV and the glucose metabolism 
determined by kinetic modelling (Minn et al., 1993). It is important to remark that the 
SUV approximation works for FDG because it remains trapped in the cells, which is a 
necessary condition for fulfilling the plateau condition. This condition is not fulfilled for 
other tracers, being one of the reasons of the widespread of FDG-PET.  
 
5.1.1 Applications of SUV in the clinical practice 
 
Recent studies have shown that most anti-cancer drugs are effective only in less than 
60% of the patients (Aspinall & Hamermesh, 2007). Thus, early understanding of the 
response of each individual patient to the treatment is of paramount importance. In this 
context, semi-quantitative measurements like SUV have proved to be more effective than 
the conventional visual assessment for distinguishing effective from ineffective treatment 
during early-stage follow-up (Wahl et al., 2009). Nowadays, all commercial PET 
scanners automatically calculate SUV, providing the physicians with quantitative values 
for the clinical routine, and several studies have demonstrated the usefulness of these 
values on the clinical practice.  
 
One of the tumour types where SUV quantification plays a major role from its early 
days is lymphoma. It has been shown that the use of SUV for evaluating the response to 
first-line chemotherapy improves the prognostic value of early FDG-PET (Lin et al., 
2007). The predictive accuracy of PET improves from 65% to 76% when quantitative 
analysis is added to a visual score. Furthermore, SUV is also used for determining the 
need of a biopsy after treatment of lymphomas (Ben-Haim & Ell, 2009).  
 
Despite FDG-PET has limited value in the initial diagnosis and staging of breast 
cancer, it has proven to be useful for the detection of primary invasive breast cancer and 
especially in the assessment of disease recurrence, with an overall accuracy of 90%, and 
has been shown to guide changes in the management of up to 50% of these patients. SUV 
values has been used for the assessment of early response to therapy, and a reduction in 
the SUV as early as 8 days after initiation of therapy has been calculated in successful 
treatments (Cochet et al., 2014), preceding anatomical changes. After the first course of 
therapy, complete responders show a mean decrease in SUV of 85%, compared with a 
22% decrease in non-responders. After two courses, SUV can predict pathological 
response with an accuracy of 87%, significantly higher than that of conventional imaging. 
Moreover, in multivariate analysis the change in SUV was the only factor predictive of 
complete response (Rousseau et al., 2006). 
 
FDG-PET has also been extensively used in the diagnosis and staging of lung cancer. 
For diagnosis of lung nodules, the positive and negative predictive values are 91%, and 
92%, respectively. A preoperative maximum SUV of 5.5 or higher is considered an 
independent predictor of relapse and death. There is also a close correlation of the change 
in SUV and the tumour response to therapy using a reduction of 20% in tumour SUV as 
a criterion for metabolic response (Weber et al., 2003). 
 
Furthermore, SUV measurements of pre-therapy tumours have also been shown to 
predict survival in oesophageal cancer (Yanagawa et al., 2012), and some publications 
have shown the usefulness of SUV values for the early assessment of response to therapy 
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and in patients with ovarian cancer, uterine cancer, head and neck squamous cell 
carcinoma, sarcoma, mesothelioma, and melanoma (Ben-Haim & Ell, 2009). 
 
5.1.2 Limitations of the SUV 
 
Although the potential of quantitative FDG-PET has been clearly demonstrated and 
SUV values are routinely measured in most centres (90%) (Beyer, Czernin, & 
Freudenberg, 2011), large variations across institutions have been reported because of 
different procedures and methodologies (Graham et al., 2011), showing the necessity of 
standardized protocols (Adams et al., 2010). SUV values must be used carefully since 
they are affected by many different factors. Error sources affecting SUV values are 
divided in two groups, those related with physiological variability issues and those 
attributable to technical parameters related to the acquisition, reconstruction and 
quantification protocols. Recently, comprehensive descriptions of the different variability 
factors have been performed and new protocols for the standardization of FDG-PET 
studies in multicentre trials have been proposed (Boellaard et al., 2008; Boellaard, 2009). 
These guides include recommendations for patient preparation, in order to minimize 
physiological variability, and for administered FDG dose, acquisition protocol 
parameters, tomographic reconstruction and quantification procedures. Other technical 
and clinical studies have also been published in order to understand some of these factors, 
thus enabling a more accurate interpretation of SUV values. Regarding the physiological 
variations, high blood glucose level (Hoekstra et al., 2002), patient motion, (Lee et al., 
2013) and high uptake in brown fat due to patient stress (Alkhawaldeh & Alavi, 2008) 
have been related to lower tumour SUV values. Regarding acquisition and reconstruction 
protocols, low spatial resolution or insufficient convergence can lead to lower SUV 
values, particularly for small lesions (Visvikis et al. 2012; Jaskowiak et al., 2005; 
Villeneuve et al., 2013). Finally, regarding the quantification procedure, SUV outcome 
depends on the region of interest (ROI) volume and type (Boellaard et al., 2004; 
Sattarivand & Caldwell, 2010) and SUV normalization (Hoekstra et al., 2002). These and 
other factors affecting SUV are summarized in Table 8.1. 
 
5.2 BEYOND SUV 
 
5.2.1 Metabolic Tumour Volume (MTV) and total lesion glycolysis (TLG) 
 
Due to the high variability of SUV, different alternative measurements may offer 
benefits to PET imaging diagnostics. Metabolic Tumour Volume (MTV) is defined as the 
volume of tumour cells with increased FDG uptake, while total lesion glycolysis (TLG) 
is obtained by multiplying𝑀𝑇𝑉 ∗ 𝑆𝑈𝑉𝑚𝑒𝑎𝑛 . Both parameters have shown promising 
results for patient prognosis and response to therapy on the clinical practice (Kiyohara et 
al., 2010), but they are compromised by the good delineation of the tumour, which has 
been a controversial topic since the start of PET quantification.  
 
5.2.2 Heterogeneity and textural analysis 
 
Tumour heterogeneity is defined as the coexistence of different types of cancerous 
cells with different morphology and physiologic behaviour within the same tumour. 
Recently, several studies have tried to develop parameters measuring tumour 




heterogeneity, which is related with disease evolution, response to therapy and 
malignancy, since heterogeneous tumours have worse outcome and response to treatment. 
Because biopsy probes reflect only a particular part of the tumour, they will not reflect 
tumour heterogeneity, which could be analysed using alternative techniques such as 
imaging (Buvat et al., 2015). In FDG-PET, heterogeneity is evaluated as spatial variations 
in uptake represented by textural features, computational methods that can measure the 
relations between adjacent groups of pixels. These methods have been previously used in 
MRI and CT imaging (Lambin et al., 2012; Rahim et al., 2014), and have arrived to PET 
imaging in the last decade. Recent papers have pointed to the fact that there is a 
relationship between PET textural features and malignancy in different types of cancer 
(Soussan et al., 2014). An example can be observed in Figure 5.1. 
 
Factor Affecting SUV Effect 
Blood glucose level 
Increasing blood glucose level is correlated with 
lower uptake and SUV. 
Uptake period 
Higher SUV at increasing time interval between 
injection and start of PET study. 
Patient motion/breathing 
Image artefacts in case of mismatch in position 
between CT-AC and emission scan and lower SUV 
due to respiratory motion due to resolution loss. 
Patient comfort 
Patient stress and uncomfortable waiting 
conditions increase uptake of FDG in muscle 
and/or brown fat and may affect SUV 
quantification. 
Inflammation 
Inflammatory processes near or at the tumour 
results in a false positive increase of SUV. 
Paravenous administration of FDG 
Paravenous injection results in slow delivery of 
FDG to the tumour and therefore in incorrect 
SUV. 
Scan acquisition parameters (acquisition mode, 
scan duration, bed overlap, FDG dose) 
Affect signal to noise ratio (SNR) of PET scan. 
Poorer SNR results in an upward bias of SUV. 
Image reconstruction settings (number of 
iterations, filters, matrix size, zoom factors) 
Insufficient convergence and lower resolution 
results in lower SUV and increases partial volume 
effects. Moreover, insufficient convergence 
makes SUV more dependent on surrounding 
activity distributions. 
Region of interest (ROI) strategy to derive SUV  
Higher or lower SUV depending on size and type 
of ROI used. 
Normalization factor in SUV calculation 
SUV outcomes are numerically different when 
using body weight, body surface area or lean 
body mass as normalization factor in the SUV 
equation. 
Correction for blood glucose level in SUV 
calculation 
Higher blood glucose levels will result in 
underestimation of SUV. Use of a blood glucose 
level correction in the SUV equation will thus 
result in different SUV outcomes. 
Use of contrast agents during CT-AC 
Can result in overestimation of attenuation and 
thus results in higher SUV (upward bias). 
  
Table 8.1: Main factor affecting SUV. Data reproduced from (Boellaard et al., 2008). 
 





Figure 5.1: High-Gray-level Run Emphasis (HGRE) textural feature calculations for different breast 
tumours. A triple negative tumour shows higher SUV than a more aggressive luminal B tumour. 





























6 MONTE CARLO SIMULATION 
 
Monte Carlo (MC) simulation techniques make use of random numbers as the base 
to simulate any specific situation. These methods are used to solve very complicated 
deterministic problems by applying a statistical approach. The implementation of modern 
MC methods and its application to physics problems have to be acknowledged to 
Stanislaw Ulam, who developed the methods while working on the Manhattan Project. 
Since then, MC methods have been extensively applied to physics and other fields of 
science (Raeside, 1976). MC methods were originally named statistical sampling 
methods, but due to the similarity between its random behaviour and casino games such 
as wheels or roulettes, they were finally named MC simulations, in reference to the Monte 
Carlo casino in Monaco. MC simulation relies in the fact that the simulated physical 
processes which can be modelled from probability density functions (PDF). Due to the 
stochastic nature of emission radiation, transport and detection, SPECT and PET systems 
are ideal for Monte Carlo techniques (Andrea, 1991). 
 
6.1 MC METHODS IN NUCLEAR MEDICINE 
 
The advance in computer power and the availability of parallel processing systems 
has increased the use of the MC techniques as a research tool for emission tomography, 
mainly for simulating the physical processes inside the scanner. It can serve for evaluating 
and improving design, corrections, dosimetry and acquisition, reconstruction and 
quantification protocols. Figure 6.1 shows the increase of the number of papers using MC 
simulation for radiation physics research from 1970 to 2000. MC simulations have 
multiples advantages with respect to the experimental measurements. For instance, the 
simulations yield information about the system that is impossible to obtain by physical 
measurement. Furthermore, a simulation can often be carried out quickly and cheaply, 
while experimental measurements are often very expensive. For radiation transport 
problems, the computational model includes geometry and material specifications. Every 
computer code contains a database of experimentally obtained quantities, known as cross-
sections, which determine the probability of a particle interacting with the medium 
through which it is transported (Zaidi, 1999).  Nowadays, MC methods are used in 
emission tomography to optimize design parameters such as sensitivity and resolution, to 
study image degradation issues such as attenuation, scatter, positron range or statistical 
noise, or to evaluate correction methods, image reconstruction algorithms and 
quantification methods.  
 
6.1.1 MC methods for assessing quantification methods 
 
SUV has been much discussed it is not still widely accepted (Visser et al.,2010). This 
is due to that the uncertainties affecting the SUV are not well documented, in particular 
those accounting for changes during the treatment. SUV can be affected by many different 
parameters, for example those accounting for physiological changes between patients or 
between the same patient and those attributable to technical issues related to acquisition, 
reconstruction and quantification protocols (Boellaard, 2011). In the last years, several 
descriptions of the variability sources affecting PET quantification have been published 
in literature, enabling a more accurate interpretation of quantitative values. Using 




anthropomorphic physical phantoms carries out a lot of these studies, being these 
phantoms ideal for the investigation of the impact of changing technical factors on the 
output images, enabling us for applications where patients cannot serve or should not 
serve (Schwartz et al., 2011). The limitations of these physical phantoms are reduced 
flexibility for changing shapes and volumes of the internal structures, high cost and 
cumbersome to use. The usage of radioactivity sources and manipulation of radiotracers 
are also a shortcoming on pure research facilities. An alternative is the use of digital 
phantoms, so that simulated PET studies are generated from the projection of phantoms 
by using analytical or Monte Carlo (MC) simulation techniques (Zaidi, 1999). Simulation 
techniques have been used to evaluate different parameters of PET systems and to assess 
potential issues on design that would be very complicated, expensive and time demanding 
on the hardware development phase, and they have become essential for nuclear medicine 
system design (Popota et al., 2015). Furthermore, MC methods are also used to the 
evaluation of scatter and attenuation correction methods, motion correction and 
reconstruction algorithms and quantification methods (Rogers, 2006). 
 
 
Figure 6.1: Number of published papers on MC simulation applications in medical radiation physics from 
1970 from 2000. Figure reproduced from (Buvat & Castiglioni, 2002)  
 
Due to the active use of these techniques, many different software alternatives 
specific for nuclear medicine are available right now for the MC simulation of PET 
systems, being the most widely used GATE (GEANT4 Application for Tomographic 
Emission) (Jan et al., 2011) and SimSET (Simulation System for Emission Tomography). 
While GATE is a powerful tool for PET detector design in the lowest level, SimSET 
provides much faster data generation while providing less detail into the simulation, 
without integrated models for system electronics and signal processing and more basic 
photon transport physics. Figure 6.2 shows an example of a MC simulation performed 
with Gate version 6.2 
 





Figure 6.2: MC simulation of a partial ring PET scanner.  Reproduced from Gate Collaboration web 
page. 
 
6.1.1.1 SimSET 2.9.2 
 
SimSET 2.9.2 (Simulation System for Emission Tomography, version 2.9.2) is an 
open-source dedicated MC code for use in molecular imaging developed by Robert 
Harrison in the University of Washington Imaging Research Laboratory since 1993 
(Harrison, 2010). The software is written in C-language and divided in modules (mainly 
object, detectors, collimators, photon history generator and binning).  
 
SimSET detector module provides a range of different detector models of increasing 
complexity. The photon history generator tracks photons through the specified object and 
detector, recording the interactions within them for each photon. The interactions are used 
to compute a detected location and total energy deposited on the detector. The simplest 
of SimSET detectors is the 'simplePET' model. This model does not simulate any detector 
interaction, taking account only of the object photon propagation. Finally, it applies an 
analytical Gaussian blurring on detected energy to emulate the limited energy resolution 
and it bins the data on the specified number of bins by the binning module. Main 
counterpart of the ‘simplePET’ is that detection efficiency is 100%, needing large 
correction factors in order to provide realistic noise to the images. The 'cylindricalPET' 
detector software models the detector as a series of adjacent regular right cylinders with 
transaxial layers. Photon interactions within the detector including scatter, absorption, 
and depth of interaction are simulated, but there are no blocks and hence no gap effects 
that are only present in the block detectors, so sensitivity is slightly overestimated. This 
simulation model is much more accurate than the simplePET, but also more time 
consuming due to the simulation and tracking of each individual photon through the 
detector. Efficiency correction factors are applied to compensate for differences in 
scintillator volumes and sensitivity due to the lack of gaps between the detectors. Random 
coincidences are added analytically after the simulation using the tools provided by tools 
provided by the library but they require storing the data in list mode. SimSET MC 
simulation toolkit provides since version 2.9.2 the ability of simulating block detectors, 




providing a new layer of complexity to perform more realistic simulations. Unfortunately, 
these more realistic simulation techniques also have an impact on time performance. 
 
6.2 ANTHROPOMORPHIC PHANTOMS 
 
Despite the huge advances in the development of Monte Carlo Codes for nuclear 
medicine, another key part for obtaining a realistic simulation is the availability of the 
necessary phantoms, computational models that are used for the representation of patients 
in simulation experiments in order to develop new image-reconstruction and processing 
algorithms. These anthropomorphic phantoms can be defined by mathematical functions, 
digital (voxel-based) volume arrays, or hybrid equation-voxel models. Mathematical 
models are built by combining simple continuous objects in order to obtain the most 
realistic possible representation of the human body, while voxel-based models are derived 
from segmented and labelled voxels from patient’s medical images of different 
modalities. While voxel-based models are usually more realistic, mathematical models 
assume that any complex radioactivity distribution and corresponding attenuation 
properties of the human body can be modelled with simplified geometrical shapes. In 
contrast, mathematical models are more suitable for applications involving anatomical 
variability and temporal changes such as respiratory or cardiac motion corrections (Zaidi 
& Xu, 2007). Since the start of the development of mathematical phantoms, many efforts 
have been done to deliver most accurate phantoms. Of these, the most wide-spread have 
been the ones provided by the Medical Internal Radiation Dose (MIRD) Committee of 
the Society of Nuclear Medicine (SNM) in the United States (you can see the current 
version on Figure 6.3). For many years, these stylized models have served to the 
radiation-protection community.   
 
 
Figure 6.3: Female MIRD phantoms for different ages.  Licensed under Public Domain via Commons. 
 
Unlike mathematical whole-body phantoms, voxelized phantoms are image-like data 
containing a huge number of tiny cubes grouped to represent each anatomical structure. 
The creation of a voxelized phantom involves the acquisition of a set of medical images 
and the (usually manual) segmentation of the different organs, which is a very time-
consuming and laborious process (Zaidi & Xu, 2007).  The most popular voxelized 
anthropomorphic phantom was developed by Zubal et al. (1994) from Yale University in 
1994, and it is known as the VoxelMan or just the Zubal’s phantom, being the first 
computational model developed for optimizing nuclear medicine imaging protocols. 
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Other relevant voxelized phantom is the VIPman (Xu et al., 2000), one of the most 
realistic computerized phantoms until know, based on cross-sectional photography of a 
39-year-old male corpse. The detail difference between the VIPman and the mathematical 
models of MIRD can be observed in Figure 6.4.  
Figure 6.4: (a) Comparison of axial sections from the MIRD (top left) and the VIPMan phantom (top 
right), showing the details from the liver (black) area. (b) 3D model of the VIPman torso. (c) 3D model 
of the VIPman head. Figure modified from (Zaidi & Xu, 2007).   
6.2.1 The XCAT Phantom 
In addition to mathematical and voxelized models, recent developments are centered 
on hybrid phantoms exploiting the advantages of the two types. Hybrid phantoms are 
based on segmentations of real data, that later is processed with polygonal meshes to 
define each anatomical object, usually by using non-uniform rational B-splines 
(NURBS), which can accurately model any surface on the body, providing mathematical 
models while preserving the details of voxelized phantoms. Of these phantoms, one of 
the most popular is the 4D extended cardiac-torso (XCAT) phantom (Seagars et al., 
2010). The XCAT phantom provides the details in the VIPman, while adding versatility 




to have phantoms of different genders and ages (See Figure 6.4) and mathematical models 
for cardiac and respiratory motion.  
 
 
Figure 6.4: XCAT phantom models for different ages and genders. Image is reproduced from the 
Duke University File (Duke File #: 3513). 
 
Recently, respiratory-induced errors in tumour SUV were recently evaluated by using the 
XCAT anthropomorphic digital phantom (Geramifar et al., 2013). Multiple PET studies 
were simulated from analytical projections of the phantom. The use of Monte Carlo 






























7 AIMS OF THIS THESIS 
 
7.1 STATEMENT OF THE PROBLEM 
 
Although the information from PET images has been traditionally evaluated by a 
qualitative visual inspection, the current trends in PET clinical research advance towards 
the quantitative analysis, which provides reliable and reproducible numerical measures 
that cannot be obtained qualitatively, offering additional information for a more precise 
diagnosis. Despite the good results provided by SUV during years, significant efforts are 
still needed to apply SUV in differential diagnosis, and especially in treatment follow-up, 
where the necessity to detect smaller changes requires a better understanding of SUV and 
its uncertainty. Regarding this, both the image quality and the quantitative accuracy of 
PET can be degraded by several effects, which we tried to describe in the previous 
sections. First, we identified physical factors such as gamma photons undergoing scatter 
processes prior to detection (scattered coincidences), two photons which do not arise from 
the same annihilation being detected within the same coincidence time window (random 
coincidences), positron range or non-collinearity, which can degrade PET data 
acquisition. In addition, the number of detected coincidences is limited and the effect of 
image noise can be important, while the requirements of administering smaller doses due 
to radiation protection need to be fulfilled. Second, we discussed physiological changes 
between patients and between different studies on the same patient, such as different 
glucose levels, inflammation, variations in the accumulation of the radiotracer in the 
bladder or muscular uptake due to stress, discomfort or cold. Finally, we reviewed 
technical factors related with patient handling (residual activity in the syringe, paravenous 
injection, variable uptake period), reconstruction (insufficient iterations, bad co-
registration between attenuation and activity, etc..) or quantification (bad ROI placing, 
bad SUV normalization). Many studies have been published in the last decade evaluating 
some of these factors. Most of these studies are carried out by using anthropomorphic 
physical phantoms or patient data. Physical phantoms are ideal for investigating the 
impact of changing technical factors on the output images, enabling us for applications 
where patients cannot serve or should not serve, but they have reduced flexibility for 
changing shapes and volumes of the internal structures, high cost and cumbersome to use. 
Patient data offers a very realistic framework for evaluating different parameters related 
with the number of counts, the reconstruction or the quantification procedures, but they 
are not suitable for many other the applications. As an alternative, MC simulation is a 
very appealing solution since it is cheap, it does not require the use of radioactivity 
sources, and it provides a well-controlled framework where all the parameters are known 
a priori, allowing a precise evaluation of each individual uncertainty source.  
Nevertheless, the simulation of realistic patient studies requires a solid methodology 
including a deep understanding of the studied problem, in order to generate realistic 
databases of digital phantoms, the use of validated MC models of the real scanners and a 
good reproduction of the reconstruction process. 




7.2 GENERAL AIM 
 
The general aim of this thesis was the evaluation of the different factors affecting 
SUV and the development of correction and standardization methods for improving the 
quantification accuracy of Positron Emission Tomography (PET) images. 
 
7.3 SPECIFIC AIMS 
 
a) Evaluation and correction of the impact of the extravasation of the injected dose 
in whole-body PET studies. 
 
b) Evaluation of the robustness of different SUV metrics (SUVmax, SUVmean, 
SUVpeak) in low-dose studies, in terms of accuracy and reproducibility. 
 
c) Evaluation of the impact of variable muscular uptake due to patient stress, 
discomfort or cold, in SUV quantification. 
 
d) Evaluation and correction of the impact of spill-in counts coming from the bladder 






























8 COHESION OF THIS THESIS 
 
The cohesion of this thesis comes from the development of a methodology for the 
Monte Carlo simulation of clinical studies, and its application to different problems 
related with SUV variability. The designed workflow is based on the generation of 
simulated whole-body 18F-FDG and 18F-Fluorocholine (FCH) studies using SimSET, 
STIR and the XCAT phantom. All phantoms were based on the anatomy of an average 
Caucasian adult male human (172 cm, 76 Kg) and the uptake of the different tissues and 
radiotracers was obtained from real patients derived to our Nuclear Medicine Department 
and from bibliography, which provides activity concentrations, contrast ratios or SUV 
variations with time measured on patient studies.  
 
The simulation of the generated phantoms was performed using the SimSET 
package. The scanner geometry was based on the General Electric (GE) Advance NXi 
PET scanner present at our Nuclear Medicine Department. Our model was based on 
previous models developed with SimSET and GATE (Barret et al., 2005), and was 
validated by comparing real and simulated NEMA tests, obtaining an accuracy within 5% 
in terms of resolution, sensitivity, scatter fraction, contrast recovery and noise. Realistic 
acquisition times of 300 seconds per bed were simulated. The number of simulated 
photons was carefully adjusted to obtain realistic signal-to-noise ratios, and the 
simulations were performed on a computer cluster with computer nodes including a 
Xeon® Processor E5-2418L (Intel Corporation, Santa Clara, California, United States) 
and 8 GB DDR3 RAM. Each simulation was performed on an individual node divided 
on 8 sub-processes in order to use the eight threads of the processor. Variance reduction 
tools on SimSET were activated to improve simulation times. Each simulation consumed 




Figure 8.1: Example of the simulation and reconstruction process. We can see the SimSET 
simulated sinograms (left), the sinograms after attenuation and scatter correction (center) and the 
reconstructed image (STIR) of the NEMA IEC phantom (right). 
 
Attenuation and scattered photons were pre-corrected before the reconstruction, 
following the methodology followed for the particular system by the scanner 
manufacturer (Bailey & Meickle, 1994). The reconstruction was performed (if the 
contrary is not stated) with the OSEM implementation present in STIR library release 2.2. 
Reconstruction parameters were tuned to fit those in the scanner. Sixteen full iterations 




were performed (16 sub-iterations, 2 subsets), and no post-filtering was applied. Matrix 
and voxel size of the reconstructed images were 128x128x35 and 4.3x4.3x4.47 mm3 
respectively, as in the manufacturer protocols. An example of the simulation and 
reconstruction process is shown in Figure 8.1. This framework enabled us to compare the 
SUV values obtained from the simulated PET images with the real SUV value (simulated 
value), thus making it possible to evaluate the accuracy and repeatability of SUV 
quantification under different conditions. An example of the workflow is shown in Figure 
8.2. This methodology was applied to four different problems affecting SUV robustness 
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MC simulation is a very interesting approach for the evaluation of PET acquisition, 
reconstruction and quantification methods. It does not require the use of radioactivity 
sources, it provides a well-controlled framework where all the parameters are known a 
priori, and it allows a precise evaluation of each individual uncertainty source.  
Nevertheless, the simulation of realistic patient studies requires a solid methodology 
including the generation of realistic databases of digital phantoms, the use of validated 
MC models of the real scanners and a good reproduction of the reconstruction process.  
 
As a first part of this thesis, we have developed a methodology for the simulation and 
reconstruction of studies from the GE Advance NXi scanner. The main objective was to 
have a framework for the simulation of clinical PET studies from our scanner. This 
methodology was afterwards applied to different problems related with SUV uncertainty. 
The selected problems were the dose extravasation due to a paravenous injection of the 
radiotracer, the image noise due to low dose, the SUV variations due to the physiological 
variations of SUV uptake and the spill-in effect when evaluating areas surrounded by 
high activity sources. After the development of the MC model, the challenge for each of 
these evaluations was the generation of realistic anthropomorphic phantoms including 
these effects.  
 
First, we evaluated the impact of dose extravasations in the SUV. The evaluation, 
based on XCAT phantom, was carried out in order to mimic complex patient 
extravasations varying shapes, volumes and concentrations. Proper activity indexes for 
different organs and tissues were used to simulate the normal physiologic distribution of 
the FDG tracer, and volumes of different complex shapes were added in the 
anthropomorphic phantom’s arm in order to mimic real extravasations in patients. The 
extravasated doses were simulated by adding volumes of different and complex shapes 
on the patient arm. Two methods for estimating the extravasated dose were proposed 
(manual-based and threshold-based) focusing in accuracy and easiness in order to enable 
a future clinical application, and their accuracy and repeatability were evaluated using 
our MC methodology.  The performance of both methods showed relative bias below 5% 
for PVI doses higher than 1% of the injected dose. Although the PVI volume could be 
more closely encapsulated by using the threshold segmentation (only predefined simple 
shapes were used in manual ROI method), a similar performance was found for manual 
and threshold ROI methods. The problem was then evaluated in patient studies. A visual 
inspection of our patient database (1367 patients) revealed that 18% of the patients 
presented some kind of paravenous injection, which was in good agreement with previous 
works (Osman et al., 2011; Hall et al., 2006). The subsequent analysis of the patient 
database by using the validated PVI estimation methods showed that only a small fraction 
of the patients (2%) presented PVI doses higher than a 1% of the injected dose. 
Nevertheless, the extravasated dose was important in some patients, with values up to a 
maximum of a 22% of the injected dose, and was especially important for paediatric 
studies. It has to be mentioned that different repeatability studies have shown that SUV 
uncertainty is around 10% (Kinahan & Fletcher, 2010; Schwartz et al., 2011), so in these 
cases PVI contribution would be very relevant. Applying the proposed correction 
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methods, doses can be estimated with an error below 5%, allowing an accurate estimation 
of the SUV quantification on these FDG-PET studies.  
 
For the evaluation of noise and the performance of SUV in low dose PET, we added 
three spherical lung lesions to our anthropomorphic activity and attenuation maps in order 
to mimic solitary pulmonary nodules with a theoretical SUV of 4.3 and diameters of 31, 
21 and 9 mm. SUVmax, SUVmean and SUV50 were obtained from the different noise 
realizations, injected doses and tumour sizes. The obtained SUV values were averaged 
over noise realizations and then compared to the simulated SUV values for different 
tumour sizes and injected doses. The repeatability of the SUV measurements was 
evaluated as the Standard Deviation (STD) of the ten simulations. Our results showed an 
overestimation associated with SUVmax, which can be explained by the statistical noise 
level. SUVmean showed significant underestimations for all lesion sizes and without 
significant changes with the injected dose. This can be explained by the partial volume 
effect, due to which part of the tumour activity is outside the delineated tumour ROI. 
Finally, SUV50 provided the best match to the simulated values, with excellent accuracy 
for lesion sizes of 31mm and 21mm, and only a slight underestimation for the smallest 
lesion. Nevertheless, in most cases, SUV estimations matching the real uptake values are 
not required in clinical routine, where SUV estimations are compared with estimated 
values from other FDG-PET studies. In this regard, the repeatability of SUVmax and 
SUV50 estimations was ranged between 2% and 8% for injected doses greater than 3mCi 
and it increased significantly for doses below this value. Instead, the variability of 
SUVmean was below 5% for all lesion sizes and injected doses greater than 3mCi. In terms 
of repeatability, the tumour quantification based on SUVmean showed a better performance 
than SUV50, in particular for small lesions, where the ROI used for SUV50 estimation had 
a very small number of pixels, making SUV50 very similar to SUVmax. Overall, SUV50 
showed better performance for accurately estimating tumour SUV values. These results 
were in agreement with recently reported data that showed SUV50 provides accurate 
quantifications (Sher et al., 2016). On the other hand, SUVmean showed better results in 
terms of repeatability. This is because ROI delineation for SUV50 depends on the value 
of a single-pixel maximum. Another remarkable observation is that a reduction of dose 
in the range from 9 to 3 mCi would not affect significantly the results of quantification 
when SUVmean and SUV50 estimations were used. It can be expected that further studies 
in modern scanners could demonstrate that these doses can be even lower. It has to be 
pointed that we did not perform any detectability studies, so image quality degradation 
due to the increased noise might have an impact on the diagnostic quality of the images. 
Nevertheless, our results might be useful for treatment follow-up, were the position of the 
lesions is previously known and the interest is on the evolution of SUV values during 
time.  
 
The impact of muscular uptake in the SUV values was evaluated by using a new 
model for including physiological muscular uptake changes in the anthropomorphic 
phantoms from the previous work. Our model was based on the tracer-stealing 
phenomenon (Lindholm et al., 2013), so that higher muscular uptake gives rise to lower 
uptake in other tissues and lesions. This work tries to demonstrate that, as long as the 
injected doses are maintained, FDG distribution constitutes a relative mechanism. 
Physiological muscular uptake values were obtained from patients remitted to our center 




quantification was assessed as deviations from the mean value (in %), obtained by using 
SUVmax, SUV50 and SUVmean, and different tumor sizes (9mm, 21mm and 31mm). The 
variability estimations were 17-22% in SUVmax, 10-19% in SUV50 and 8-10% in SUVmean 
(intervals are related to the three lung lesions). We observed that the variability in tumor 
quantification was mainly affected by muscular uptake variations for tumor sizes of 
21mm and 31mm, while statistical noise is the dominant source of variation for tumors 
as small as 9mm. The latter statement is also true for low injected activities, but the 
variability is strongly affected by statistical noise when the injected activity is below 
222MBq. Our findings revealed that the SUV variability could be dominated by muscular 
uptake changes between relaxed patients in certain circumstances. In particular, our 
results showed that muscular uptake has to be taken into account as a source of 
uncertainty, significantly higher than the statistical noise, for large tumors (>2cm) and 
commonly injected activity values (>222MBq). Instead, the impact of muscular uptake is 
much lower when considering small tumors (<2cm) or lower injected activities (below 
222MBq), where statistical noise is still the main contribution to the variability. The main 
contribution of our work was to generate the first database of simulated PET studies 
including a realistic model of muscle uptake variations. This database was used for 
addressing the impact of muscular uptake on PET quantification, providing an accurate 
estimation of SUV variability. According to our study, in a common PET scan, the 
estimation of SUV is affected by variability values of at least 8-10%. It is convenient to 
evaluate the variability related to muscular uptake changes in the context of previously 
reported uncertainties associated to SUV measurements. First, it has to be mentioned that 
the PET response criteria in solid tumors (PERCIST) classification system assumes a 
biologic change with SUVpeak about 30% (de Langen et al., 2008). Furthermore, a recent 
work (de Langen et al., 2012) determined the repeatability of different SUV 
measurements using previously published data, providing variability values in SUVmean 
estimations about 20%, which are according to earlier reported values (Hoekstra et al., 
2002).  Therefore, we can conclude that muscular uptake variations between relaxed 
patients represent a significant uncertainty source for tumor quantification values in PET 
studies. Nevertheless, the simple model used to propagate the effect of the muscular 
variations limits our work’s scope, and further assessment of the current effect needs to 
be done using more realistic approaches.  
 
Finally, we developed and tested a novel software-based correction method that 
allows us to correct the effects of bladder accumulation on 18F-based radiotracers, and 
that is potentially applicable to other situations. A modified version of the 
anthropomorphic XCAT2 phantom was obtained by including typical 18F-FCH 
distribution, uptake variations for the bladder and prostatic lesions. A hot spot (24 ml) 
was added to the prostatic left lobe in order to simulate a primary prostate tumour or local 
recurrence. The phantoms were generated with different combinations of prostate, tumour 
and bladder activities. Different bladder volumes were also simulated. Our results 
revealed that the measured SUV values could be biased as much as 41.3% for SUVmax 
and 22.2% for SUVmean when the bladder SUV varies on a range from 1.01 g/l to 18.19 
g/l, with strong dependence on bladder/lesion ratio. These results reveal that the 
quantification on the prostatic area is very sensitive to variations on bladder accumulation, 
which is dependent on physiological factors, suggesting that uncorrected 18F-FCH might 
not be an appropriate radiotracer for quantification of tumours in this area, with 11C-
labelled choline analogues providing a more reliable solution. The prevention of this 
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effect with bladder voiding, or the usage of a proper correction methods is mandatory. 
We proposed a correction method based on the hypothesis that spill-in counts from the 
bladder could be corrected with appropriate modification of the reconstruction process. 
The bladder is segmented from the conventional reconstructed PET image using a 
manually drawn ROI. After the segmentation, the bladder is analytically projected with 
the same projector that is used for the iterative reconstruction, generating new analytical 
sinograms of the bladder only. Following segmentation and forward projection, the 
reconstruction of the original sinograms is performed again, with the bladder sinograms 
as a physiological background term for the reconstruction. The process is mathematically 
the same as used for standard scatter and random coincidences corrections. This new 
method was applied to all the simulated images and the result is an image without the 
bladder contribution. We compared the SUVmax and SUVmean quantification values before 
and after the correction. After the correction, the images provided higher accuracy and 
repeatability of both SUVmax and SUVmean values, with good repeatability and in good 
agreement with simulated SUV values and quantified values without bladder uptake 
respectively. The usage of the method makes possible a reliable use of SUV on prostatic 
lesions when injecting 18F-FCH, at least from a reconstruction point of view. More 
experiments are needed to ensure the applicability of the proposed method to patient 
studies and modifications of the methodoly might be necessary when applying it to the 
clinic, particularly related with the segmentation of the bladder that can be hindered by 
the physiology of clinical PET studies. These and other factors affecting the segmentation 
such as influence of patient movement and bladder volume variations are out of the scope 
of this work but subject of future investigations.  
 
In summary, we have developed a methodology that allowed us to obtain simulated 
whole-body studies comparable to the ones obtained in our scanner. This methodology, 
combined with novel anthropomorphic patient databases, allowed us to evaluate the 
impact of different effects over the SUV values. We chose and evaluated four different 
effects, and proposed corrections and recommendations for each of them, allowing a more 
comprehensible and precise quantification of PET images. The developed methodology 






















































14  CONCLUSIONS 
 
 
During this thesis, different factors affecting SUV were evaluated, resulting on 
correction methods and different recommendations for improving the accuracy of PET 
quantification methods: 
 
a) Different methods for estimating the extravasated dose in FDG-PET studies were 
developed, extensively validated by using Monte Carlo simulations, and then 
applied to patient studies. Our findings revealed that paravenous injection is 
relatively frequent effect (18%), with a small fraction of the patients presenting 
considerable PVI doses ranging from 1% to a maximum of 22% of the injected 
dose. We developed and validated a fast and easy manual method based on 
predefined volumetric ROIs and background subtraction for estimating the 
effectively administered FDG dose and then correct SUV quantification. 
Applying this correction, the SUV bias due to the PVI effect can be reduced. The 
simplicity of the proposed method suggests that its clinical application would be 
feasible, so that those FDG-PET studies with remarkable extravasated doses can 
be included in quantification protocols. 
 
b) Regarding noise in low dose PET, we carried out an evaluation study of the 
accuracy and repeatability of SUV estimations obtained from FDG-PET studies 
in patients with solitary pulmonary nodules. Our findings showed that SUV50 
provides the better performance for accurately estimating tumour SUV values, 
while SUVmean provides the best results in terms of repeatability 
 
c) For studying the impact of muscular uptake variations, we generated a new 
database of simulated PET studies by using an anthropomorphic phantom of 
patients with solitary pulmonary nodules and a realistic model of muscle uptake 
variations. Our findings demonstrated that muscular uptake variations between 
relaxed patients should be considered as a significant uncertainty source of tumor 
quantification values in PET studies. 
 
d) Finally, the impact of the bladder uptake on prostate tumours quantification was 
evaluated using MC simulations. Our results showed that measured SUV can be 
biased as much as 40% when bladder/tumour ratios are high, pointing to the need 
for developing a correction methodology. A method based on the introduction of 
prior information about bladder on the reconstruction was proposed and tested, 
showing improvements both on visual detectability and quantification. Applying 
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